<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1-3.dtd?><?SourceDTD.Version 1.3?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">9866976</article-id><article-id pub-id-type="pmid">36674628</article-id><article-id pub-id-type="doi">10.3390/ijms24021114</article-id><article-id pub-id-type="publisher-id">ijms-24-01114</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Lunaemycins, New Cyclic Hexapeptide Antibiotics from the Cave Moonmilk-Dweller <italic toggle="yes">Streptomyces lunaelactis</italic> MM109<sup>T</sup></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Martinet</surname><given-names>Lo&#x000ef;c</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref><xref rid="af2-ijms-24-01114" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>Aymeric</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref><xref rid="af2-ijms-24-01114" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Rezende</surname><given-names>Lucas C. D.</given-names></name><xref rid="af2-ijms-24-01114" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tellatin</surname><given-names>D&#x000e9;borah</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Pignon</surname><given-names>Bernard</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9483-4476</contrib-id><name><surname>Docquier</surname><given-names>Jean-Denis</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref><xref rid="af3-ijms-24-01114" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3001-8159</contrib-id><name><surname>Sannio</surname><given-names>Filomena</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af3-ijms-24-01114" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1622-0118</contrib-id><name><surname>Baiwir</surname><given-names>Dominique</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af4-ijms-24-01114" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8757-8133</contrib-id><name><surname>Mazzucchelli</surname><given-names>Gabriel</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af5-ijms-24-01114" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0770-9990</contrib-id><name><surname>Fr&#x000e9;d&#x000e9;rich</surname><given-names>Michel</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af6-ijms-24-01114" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4022-7325</contrib-id><name><surname>Rigali</surname><given-names>S&#x000e9;bastien</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-ijms-24-01114" ref-type="aff">1</xref><xref rid="af2-ijms-24-01114" ref-type="aff">2</xref><xref rid="c1-ijms-24-01114" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Jarmu&#x00142;a</surname><given-names>Adam</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-ijms-24-01114"><label>1</label>InBioS&#x02014;Centre for Protein Engineering, Institut de Chimie B6a, University of Li&#x000e8;ge, B-4000 Liege, Belgium</aff><aff id="af2-ijms-24-01114"><label>2</label>Hedera-22, Boulevard du Rectorat 27b, B-4000 Liege, Belgium</aff><aff id="af3-ijms-24-01114"><label>3</label>Dipartimento di Biotecnologie Mediche, University of Siena, Viale Bracci 16, 53100 Siena, Italy</aff><aff id="af4-ijms-24-01114"><label>4</label>GIGA Proteomics Facility, University of Liege, B-4000 Liege, Belgium</aff><aff id="af5-ijms-24-01114"><label>5</label>Mass Spectrometry Laboratory, MolSys Research Unit, University of Liege, B-4000 Liege, Belgium</aff><aff id="af6-ijms-24-01114"><label>6</label>Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, B-4000 Liege, Belgium</aff><author-notes><corresp id="c1-ijms-24-01114"><label>*</label>Correspondence: <email>srigali@uliege.be</email></corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2023</year></pub-date><volume>24</volume><issue>2</issue><elocation-id>1114</elocation-id><history><date date-type="received"><day>29</day><month>11</month><year>2022</year></date><date date-type="rev-recd"><day>01</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>04</day><month>1</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 by the authors.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><italic toggle="yes">Streptomyces lunaelactis</italic> strains have been isolated from moonmilk deposits, which are calcium carbonate speleothems used for centuries in traditional medicine for their antimicrobial properties. Genome mining revealed that these strains are a remarkable example of a <italic toggle="yes">Streptomyces</italic> species with huge heterogeneity regarding their content in biosynthetic gene clusters (BGCs) for specialized metabolite production. BGC 28a is one of the cryptic BGCs that is only carried by a subgroup of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains for which in silico analysis predicted the production of nonribosomal peptide antibiotics containing the non-proteogenic amino acid piperazic acid (Piz). Comparative metabolomics of culture extracts of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains either holding or not holding BGC 28a combined with MS/MS-guided peptidogenomics and <sup>1</sup>H/<sup>13</sup>C NMR allowed us to identify the cyclic hexapeptide with the amino acid sequence (D-Phe)-(L-HO-Ile)-(D-Piz)-(L-Piz)-(D-Piz)-(L-Piz), called lunaemycin A, as the main compound synthesized by BGC 28a. Molecular networking further identified 18 additional lunaemycins, with 14 of them having their structure elucidated by HRMS/MS. Antimicrobial assays demonstrated a significant bactericidal activity of lunaemycins against Gram-positive bacteria, including multi-drug resistant clinical isolates. Our work demonstrates how an accurate in silico analysis of a cryptic BGC can highly facilitate the identification, the structural elucidation, and the bioactivity of its associated specialized metabolites.</p></abstract><kwd-group><kwd>antibiotics</kwd><kwd>cryptic metabolites</kwd><kwd>natural compounds</kwd><kwd>Anti-MRSA</kwd><kwd>moonmilk</kwd><kwd>cave microbiology</kwd><kwd>genome mining</kwd><kwd>piperazic acid</kwd><kwd>NRPS</kwd><kwd>molecular networking</kwd></kwd-group><funding-group><award-group><funding-source>Fonds National de la Recherche Scientifique (FNRS)</funding-source><award-id>FRIA1.E049.16</award-id><award-id>CDR/OL J.0158.21</award-id></award-group><award-group><funding-source>FEDER and Wallonia</funding-source><award-id>BIOMED HUB</award-id></award-group><award-group><funding-source>MIUR &#x0201c;Progetto Dipartimenti di Eccellenza</funding-source><award-id>L. 232/2016</award-id></award-group><funding-statement>This research was funded by Fonds National de la Recherche Scientifique (FNRS) S.R. wants to acknowledge grants FRIA1.E049.16 (FRIA grant to L.M. and S.R.), and FNRS grant CDR/OL J.0158.21 (Cr&#x000e9;dit de recherche, FNRS). D.B is funded by FEDER and Wallonia (BIOMED HUB Technology Support project). S.R. is a Senior Research Associate at the Belgian Fund for Scientific Research (F.R.S.-FNRS, Brussels, Belgium). J.-D.D. acknowledges the partial support by MIUR &#x0201c;Progetto Dipartimenti di Eccellenza 2018&#x02013;2022&#x0201d;, grant n. L. 232/2016 (HiProtEn).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-24-01114"><title>1. Introduction</title><p><italic toggle="yes">Streptomyces</italic> and other actinomycetes are Gram-positive filamentous bacteria that offered most of the molecules of microbial origin that are now used in human and animal therapy [<xref rid="B1-ijms-24-01114" ref-type="bibr">1</xref>,<xref rid="B2-ijms-24-01114" ref-type="bibr">2</xref>]. The urge for new structural leads for both the agro-food and pharmaceutical fields has revitalized the interest for bioprospection of microorganisms dwelling in the most diverse and extreme environmental niches [<xref rid="B3-ijms-24-01114" ref-type="bibr">3</xref>]. This quest for metabolite-producing bacteria in environments far from the ecological niches where they were mainly/originally isolated (such as rich organic soils for actinomycetes) is motivated by the idea that they would possess genetic features adapted to these specific and unusual environments, allowing them to produce uncommon &#x02018;specialized&#x02019; metabolites [<xref rid="B4-ijms-24-01114" ref-type="bibr">4</xref>].</p><p>Caves, being inorganic and extreme oligotrophic environments, were initially considered as inhospitable places for streptomycetes and other microorganisms programmed for primarily consuming nutrients derived from the plant decomposing organic matter. Instead, this phylum is surprisingly omnipresent, displaying relative abundance and diversity depending on the type of cave and speleothem [<xref rid="B5-ijms-24-01114" ref-type="bibr">5</xref>,<xref rid="B6-ijms-24-01114" ref-type="bibr">6</xref>,<xref rid="B7-ijms-24-01114" ref-type="bibr">7</xref>,<xref rid="B8-ijms-24-01114" ref-type="bibr">8</xref>,<xref rid="B9-ijms-24-01114" ref-type="bibr">9</xref>,<xref rid="B10-ijms-24-01114" ref-type="bibr">10</xref>]. One such geological formation that was previously unexpected to house a huge diversity of actinomycetes is the so-called moonmilk, a soft white carbonate deposit in limestone caves mainly consisting of microfibers of calcite [<xref rid="B11-ijms-24-01114" ref-type="bibr">11</xref>,<xref rid="B12-ijms-24-01114" ref-type="bibr">12</xref>,<xref rid="B13-ijms-24-01114" ref-type="bibr">13</xref>]. Even within the same cave, the diversity of actinomycetes can widely differ from one moonmilk deposit to another [<xref rid="B6-ijms-24-01114" ref-type="bibr">6</xref>]. More astonishingly, these bacteria do not only inhabit moonmilk to benefit from the nutrients carried by the water percolating from the surface, but they also actively participate in the creation of the mineral structure itself [<xref rid="B12-ijms-24-01114" ref-type="bibr">12</xref>,<xref rid="B14-ijms-24-01114" ref-type="bibr">14</xref>,<xref rid="B15-ijms-24-01114" ref-type="bibr">15</xref>,<xref rid="B16-ijms-24-01114" ref-type="bibr">16</xref>,<xref rid="B17-ijms-24-01114" ref-type="bibr">17</xref>,<xref rid="B18-ijms-24-01114" ref-type="bibr">18</xref>].</p><p>The decision of our laboratory to search for antibiotic-producing bacteria in moonmilk deposits originated from evidence of hundreds of years of mining activities for the use of this speleothem as powder with antimicrobial properties [<xref rid="B13-ijms-24-01114" ref-type="bibr">13</xref>,<xref rid="B19-ijms-24-01114" ref-type="bibr">19</xref>]. The first scanning electron micrographs of the calcite fibers of moonmilk also revealed filamentous bacteria further supporting the presence of microorganisms notorious as &#x02018;antibiotic-makers&#x02019; [<xref rid="B14-ijms-24-01114" ref-type="bibr">14</xref>,<xref rid="B15-ijms-24-01114" ref-type="bibr">15</xref>,<xref rid="B16-ijms-24-01114" ref-type="bibr">16</xref>,<xref rid="B18-ijms-24-01114" ref-type="bibr">18</xref>]. Indeed, each actinomycete we isolated from three different moonmilk deposits of the cave &#x02018;la grotte des collemboles&#x02019; (Comblain-au-Pont, Belgium) displayed antibacterial and/or antifungal activities [<xref rid="B9-ijms-24-01114" ref-type="bibr">9</xref>,<xref rid="B10-ijms-24-01114" ref-type="bibr">10</xref>]. A <italic toggle="yes">Streptomyces</italic> species that we found in all moonmilk deposits of the cave is <italic toggle="yes">Streptomyces lunaelactis</italic> with isolate MM109<sup>T</sup> as the archetype strain [<xref rid="B9-ijms-24-01114" ref-type="bibr">9</xref>,<xref rid="B10-ijms-24-01114" ref-type="bibr">10</xref>,<xref rid="B20-ijms-24-01114" ref-type="bibr">20</xref>,<xref rid="B21-ijms-24-01114" ref-type="bibr">21</xref>]. <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> is the first fully characterized and completely sequenced <italic toggle="yes">Streptomyces</italic> strain originating from these speleothems [<xref rid="B20-ijms-24-01114" ref-type="bibr">20</xref>,<xref rid="B21-ijms-24-01114" ref-type="bibr">21</xref>,<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>]. Genome mining of the 18 <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains revealed 42 biosynthetic gene clusters (BGC) with only 18 of them being conserved among all strains, thereby providing a remarkable example of a huge specialized metabolism heterogeneity within a single species [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>].</p><p>One of our aims in investigating cave microbiology is to identify the genetic and physiological features that make soil-dwelling bacteria to adapt to inorganic mineral environments [<xref rid="B15-ijms-24-01114" ref-type="bibr">15</xref>]. Some of these adjustments must be part of their specialized metabolism used to capture essential nutrients and compete with other microorganisms or instead contribute to the survival of the entire microbial community. In our effort to identify the metabolites produced by moonmilk-dwelling actinomycetes, interesting findings came to light, such as the discovery of the BGC responsible for the hallmark green pigmentation of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains, which revealed a unique example of a BGC involved in the production of two structurally and functionally different metabolites, namely the bagremycin antibiotics and the iron chelating molecules that generate ferroverdins [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>,<xref rid="B23-ijms-24-01114" ref-type="bibr">23</xref>,<xref rid="B24-ijms-24-01114" ref-type="bibr">24</xref>].</p><p>Herein, we report how genome mining guided MS/MS-based networking and peptidogenomics allowed the discovery, the elucidation of the structure, and the biosynthetic pathway of lunaemycins, new, potent antibiotics produced by <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup>. Lunaemycins are new, piperazic acid-containing cyclic hexapeptides able to inhibit the growth of all tested Gram-positive bacteria, including various multi-drug resistant isolates, thereby in part explaining the success of this species at colonizing extremely competitive environments.</p></sec><sec sec-type="results" id="sec2-ijms-24-01114"><title>2. Results and Discussion</title><sec id="sec2dot1-ijms-24-01114"><title>2.1. Sequence Analysis of BGC 28a and Predicted Structure of Its Associated Natural Product</title><p>Mining the genome of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> [<xref rid="B21-ijms-24-01114" ref-type="bibr">21</xref>] with antiSMASH identified BGC 28a, a ~69 kb non-ribosomal peptide synthetase (NRPS)-type BGC consisting of 39 open reading frames (ORFs) from nucleotide positions 3124 to 72,040 on the linear plasmid pSLUN1a (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref> and <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>). The <italic toggle="yes">hmt</italic> gene cluster of <italic toggle="yes">Streptomyces himastatinicus</italic> producing the antitumor antibiotic himastatins [<xref rid="B25-ijms-24-01114" ref-type="bibr">25</xref>,<xref rid="B26-ijms-24-01114" ref-type="bibr">26</xref>] is the most similar BGC of the MIBiG database [<xref rid="B27-ijms-24-01114" ref-type="bibr">27</xref>] in terms of number of homologous genes (<xref rid="app1-ijms-24-01114" ref-type="app">Figure S1</xref> and <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>). Further sequence analysis highlighted three other known BGCs sharing common features with BGC 28a, namely the <italic toggle="yes">ktz</italic> gene cluster producing the antifungal kutznerides in <italic toggle="yes">Kutzneria</italic> sp. 744 [<xref rid="B28-ijms-24-01114" ref-type="bibr">28</xref>], the <italic toggle="yes">sten</italic> gene cluster associated with the production of the antimicrobial stenothricins in <italic toggle="yes">Streptomyces roseosporus</italic> NRRL 15998 [<xref rid="B29-ijms-24-01114" ref-type="bibr">29</xref>], and the <italic toggle="yes">art</italic> BGC for the antitumor antibiotic aurantimycins produced by <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 [<xref rid="B30-ijms-24-01114" ref-type="bibr">30</xref>]. The synteny and conserved gene content of these four BGCs is relatively low with <italic toggle="yes">hmt</italic>, <italic toggle="yes">ktz</italic>, <italic toggle="yes">art</italic>, and <italic toggle="yes">sten</italic> gene clusters sharing only nine, seven, six, and four homologous genes with the 39 ORFs of BGC 28a, respectively (<xref rid="app1-ijms-24-01114" ref-type="app">Figure S1</xref>). Himastatins, kutznerides, stenothricins, and aurantimycins are all cyclic depsipeptides synthesized by NRPS or hybrid NRPS-PKS machineries [<xref rid="B31-ijms-24-01114" ref-type="bibr">31</xref>,<xref rid="B32-ijms-24-01114" ref-type="bibr">32</xref>,<xref rid="B33-ijms-24-01114" ref-type="bibr">33</xref>,<xref rid="B34-ijms-24-01114" ref-type="bibr">34</xref>], suggesting that the main product of BGC 28a should partially share some structural features and/or amino acid building blocks with these natural products.</p><p>Closer sequence analysis of the core and additional biosynthetic genes of BGC 28a allowed us to propose a biosynthetic pathway and predict the amino-acid building blocks and backbone of its main product (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>). First, as observed in the BGCs of kutznerides and himastatins, BGC 28a contains the two genes required for the biosynthesis of the non-proteinogenic amino acid piperazic acid (Piz) from L-ornithine (Orn). The first reaction is performed by the product of <italic toggle="yes">lun16</italic> encoding the flavin- and oxygen-dependent L-ornithine N-hydroxylase (SLUN_ RS38485 homologous to HmtM and KtzI, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>) to give L-N<sup>5</sup>-OH-ornithine [<xref rid="B35-ijms-24-01114" ref-type="bibr">35</xref>], which will be further converted to L-Piz by the product of <italic toggle="yes">lun17</italic> (SLUN_ RS38490 homologous to HmtC and KtzT, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>) encoding the heme-dependent piperazate synthase [<xref rid="B36-ijms-24-01114" ref-type="bibr">36</xref>]. Interestingly, genes encoding piperazate synthase are present in most BGCs for Piz-containing molecules [<xref rid="B37-ijms-24-01114" ref-type="bibr">37</xref>,<xref rid="B38-ijms-24-01114" ref-type="bibr">38</xref>], suggesting that at least one NRPS module of BGC 28a is expected to recruit Piz as building block. Next, as observed in the stenothricin gene cluster [<xref rid="B29-ijms-24-01114" ref-type="bibr">29</xref>], BGC 28a contains a transcription unit with four ORFs whose products encode the enzymes involved in the five steps of Orn biosynthesis from glutamic acid and glutamine precursors (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>). These genes/proteins are <italic toggle="yes">lun14</italic> for the bifunctional N<sup>2</sup>-acetyl-L-ornithine:L-glutamate N-acetyltransferase (SLUN_ RS38475 homologous to StenL, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>), <italic toggle="yes">lun13</italic> for the N-acetylglutamate kinase (SLUN_RS38470 homologous to StenK and HmtB, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>), <italic toggle="yes">lun11</italic> for the N-acetyl-gamma-glutamyl-phosphate reductase (SLUN_RS38460 homologous to StenM, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>), and <italic toggle="yes">lun12</italic> for the N<sup>2</sup>-acetyl-L-ornithine:2-oxoglutarate aminotransferase (SLUN_RS38465 homologous to StenJ, <xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>). BGC 28a thus contains all genes required for the enzymatic conversion of glutamic acid and glutamine to L-Piz, further supporting the recruitment of this amino acid by the NRPS machinery. </p><p>Regarding the core biosynthetic genes, three ORFs encode NRPSs with complete biosynthetic modules. The sequential order of these modules in peptide synthesis (initiation, elongation, and termination modules) is predicted based on the composition of their catalytic domains (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>). The biosynthesis would start with Lun23 (SLUN_ RS38520, providing the initiation module 1 and the &#x02018;inactive&#x02019; module 2), followed by Lun20 (SLUN_ RS38505, elongation module 3), and finally Lun22 (SLUN_RS38515, elongation and termination modules 4, 5, 6, and 7) (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>). All together these NRPSs form a megasynthetase organized into seven modules, for which the detailed analysis of the specificity-conferring sequence of each adenylation (A) domains with SANDPUMA [<xref rid="B39-ijms-24-01114" ref-type="bibr">39</xref>] allowed the prediction of the building blocks recruited by the NRPS machinery (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>).</p><p>Module 1 in Lun23 contains three domains (A-T-E) and is predicted to incorporate L-Phe (DAWTVAAVCK as 10-aa code), which would be converted to D-Phe by the epimerization (E) domain. Module 2 in Lun23 also contains three domains (C-A-T), but prediction software tools did not propose specificity to any amino acid and suggest that this module would be inactive (DVASLAAYAK as 10-aa code). Module 3 in Lun20 contains three domains (C-A-T) and is predicted to recruit L-Ile (DAFFLGVTYK as 10-aa code). The four following modules (4 to 7), all included in Lun22, are predicted to incorporate four Piz residues, two D-Piz via modules 4 (C-A-T-E) and 6 (C-A-T-E) that both contain an epimerization domain, and two L-Piz via module 5 (C-A-T) and module 7 (C-A-T-TE). Indeed, the 10 aa code sequence conferring amino acid substrate specificity for Lun22 (DVFSVAAYAK as 10-aa code for modules 4, 5, 6, and 7) is identical to the one of HmtL-A1 (DVFSVAAYAK), and highly similar to those of KtzH-A1 (DVFSVGPYAK as 10-aa code, 8/10), ArtF-A1 (DVFSVASYAK as 10-aa code, 9/10), and ArtG-A2 (DVFTVAAYAK as 10-aa code, 9/10) which were reported to recognize and activate Piz in previous studies [<xref rid="B25-ijms-24-01114" ref-type="bibr">25</xref>,<xref rid="B28-ijms-24-01114" ref-type="bibr">28</xref>,<xref rid="B30-ijms-24-01114" ref-type="bibr">30</xref>,<xref rid="B37-ijms-24-01114" ref-type="bibr">37</xref>,<xref rid="B38-ijms-24-01114" ref-type="bibr">38</xref>]. Finally, module 7 would cyclize and release the final hexapeptide via its thioesterase (TE) domain as shown for the biosynthesis of himastatins and kutznerides where the last TE domain of HmtL and KtzH, the homologues of Lun22, perform the macrocyclization of their respective final peptide [<xref rid="B25-ijms-24-01114" ref-type="bibr">25</xref>,<xref rid="B28-ijms-24-01114" ref-type="bibr">28</xref>].</p><p>In conclusion, the NRPS machinery of BGC 28a is predicted to generate an hexapeptide with the sequence D- Phe, L-Ile, D-Piz, L-Piz, D-Piz, L-Piz as backbone of its main product that, with or without cyclization, would have monoisotopic masses of 708.4071 Da (C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>6</sub>) and 726.4177 Da (C<sub>35</sub>H<sub>54</sub>N<sub>10</sub>O<sub>7</sub>), respectively.</p></sec><sec id="sec2dot2-ijms-24-01114"><title>2.2. Structure Elucidation of Lunaemycins</title><sec id="sec2dot2dot1-ijms-24-01114"><title>2.2.1. MS/MS-Based Networking and Peptidogenomics Guided Genome Mining</title><p>A peptidogenomic approach where genome mining guides the tandem mass spectrometry (MS/MS)-based molecular identification of high-resolution mass spectrometry (HRMS) data was used to identify compounds produced by BGC 28a. The predicted building-blocks can be used to screen the MS/MS fragments in order to find neutral or charged losses of amino-acids. Although BGC 28a is predicted to produce a cyclized hexapeptide of a monoisotopic mass of 708.4071 Da, we cannot exclude at this stage either modifications of one or more building blocks before their utilization by the NRPS machinery and/or post modifications of the generated hexapeptide. Therefore, the MS/MS spectra of molecular ions ranging from m/z 700 to 800 Da have been manually analyzed to identify tag fragments corresponding to the three different amino acids predicted to be incorporated by the six NRPS modules. Finally, prior to performing the comparative metabolomic analysis, genome mining of the eighteen isolated <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains revealed a genetic characteristic that is crucial for the identification of the products of BGC 28a. Indeed, BGC 28a is present in only three <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains, i.e., those that possess pSLUN1a, whereas all the other strains with the linear plasmid pSLUN1b instead comprise BGC 28b [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>] (<xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>a). <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains that possess pSLUN1b are therefore natural variants/mutants non-producing the searched compound(s) of BGC 28a, and their culture extract can be considered as negative control.</p><p>The crude extracts from eleven <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains grown on the ISP7 solid medium were collected and subjected to UPLC-HRMS/MS analysis. As explained above, metabolite profiling was performed to search for molecules with <italic toggle="yes">m/z</italic> comprised between 700 and 800 Da that were only produced by the two selected <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains that possess pSLUN1a (MM109<sup>T</sup> and MM37), and not by the nine other selected strains that instead have pSLUN1b (MM22, MM25, MM28, MM31, MM40, MM78, MM83, MM113, and MM115) (<xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>b). As shown in the heatmap of <xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>b, a series of <italic toggle="yes">m/z</italic> signals displayed contrasting production patterns between the two groups of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains. An analysis of the extracted ion chromatograms (EIC) of the full extract of the 11 <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains revealed a series of peaks only present in strains harboring pSLUN1a (<xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>c). The most intense signal has an <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of 725.4092, which is appropriate for the molecular formula of C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup> (0.17 ppm error) (<xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>d). In the same HRMS spectrum, a second ion with lower signal intensity corresponds to the [M + Na]<sup>+</sup> ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 747.3903, which corresponds to the molecular formula C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup>. The masses and formula of both proton and sodium adducts reveal that the main compound of BGC 28a has a molecular formula of C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>7</sub> (monoisotopic mass of 724.4020 Da), which from now on will be referred to as compound <bold>1</bold> (hereafter named lunaemycin A).</p><p>Interestingly, the experimentally calculated mass of compound <bold>1</bold> only differs by 16 Da compared to the mass of the in silico predicted cyclized structure of the main product of BGC 28a (<xref rid="ijms-24-01114-f001" ref-type="fig">Figure 1</xref>). From the molecular formula C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>7</sub> inferred from <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 725.41, and according to the amino acid building blocks (D-<italic toggle="yes">allo</italic>-Ile, L-Phe, D-Piz, L-Piz, D-Piz, L-Piz) predicted to be loaded by adenylation domains, compound <bold>1</bold> could correspond to either i) an open peptide with an extra unsaturation from a dehydrogenation step or ii) a cyclic peptide carrying a hydroxyl group added in an oxidation step.</p><p>An analysis of the HRMS/MS spectrum of the <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 725.41 molecular ion revealed sequence tags that allowed us to propose that compound <bold>1</bold> is the cyclized sequence of the hexapeptide Phe-OH-Ile-Piz-Piz-Piz-Piz (<xref rid="ijms-24-01114-f003" ref-type="fig">Figure 3</xref>). Indeed, the daughter ion fragments of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 596.33, 449.26, 337.2, 225.13, and 113.07 correspond to consecutive losses of (i) an hydroxy-leucine (H<sub>2</sub>O neutral loss-derived tag fragment of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 129.08), (ii) a phenylalanine (H<sub>2</sub>O neutral loss-derived tag fragment of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 147.07), followed by three consecutive losses of Piz residues (three H<sub>2</sub>O neutral loss-derived tag fragments of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 112.06), and finally, the ion fragment tag of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 113.07 corresponding to Piz+H<sup>+</sup> (<xref rid="ijms-24-01114-f003" ref-type="fig">Figure 3</xref>b). The fragmentation spectrum thus confirmed the presence of tags associated with all six amino acids predicted to be incorporated by the A domains of the active modules of BGC 28a. The only difference with the initial prediction is the hydroxylation of the Ile residue, which could be attributed to the product of <italic toggle="yes">lun21</italic> (SLUN_RS38510, <xref rid="ijms-24-01114-t001" ref-type="table">Table 1</xref>) encoding a FAD-dependent oxidoreductase, homologous to the oxidoreductase PlyE of <italic toggle="yes">Streptomyces</italic> sp. MK498-98 F14 involved in the production of polyoxypeptins [<xref rid="B40-ijms-24-01114" ref-type="bibr">40</xref>]. Indeed, PlyE is predicted to be responsible for the N-hydroxylation of valine and alanine building blocks on the nitrogen atom between Piz and Val or Ala residues of polyoxypeptin A. A similar role is also proposed for the FAD-dependent monooxygenase CchB that catalyzes the N-hydroxylation of the &#x003b4;-amino group of ornithine in coelichelin biosynthesis before its recruitment by the NRPS machinery [<xref rid="B41-ijms-24-01114" ref-type="bibr">41</xref>]. Similarly, Lun21 would perform the N-hydroxylation of the Ile residue, which would lead to the structure proposed for compound <bold>1</bold> (<xref rid="ijms-24-01114-f003" ref-type="fig">Figure 3</xref>b). Whether this N-hydroxylation of the Ile building block is performed (i) before its recruitment by the A domain of Lun20 (as suggested for coelichelin biosynthesis), (ii) once it is activated and tethered on the thiolation (T) domain of Lun20 (as proposed for polyoxypeptin synthesis) or after the formation and cyclization of the hexapeptide remains speculative at this stage.</p><p>To strengthen the reliability of the proposed structure of compound <bold>1</bold>, the <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of the MS/MS data were correlated to the structure of ions produced during the fragmentation mechanism (<xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>a). The <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of nine fragment ions can only correlate with the structure of ions containing one to four Piz residues (fragments 1&#x02013;9 in blue in <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>b). Four of these fragment ions&#x02014;<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 113.0711, 225.1347, 337.1984, and 449.2608&#x02014;can be linked to structures containing respectively 1, 2, 3, and 4 Piz residues, expected to result from sequential <italic toggle="yes">b<sub>x</sub>-y<sub>z</sub></italic> fragmentation steps. Additionally, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 309.2034 and 197.1394 result from the neutral loss of CO of the aforementioned ions <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 337.1984 and 225.1347, respectively. At least seven fragment ions contain phenylalanine&#x02019;s aromatic side chain thereby confirming the presence of this amino acid in the structure of compound <bold>1</bold> (fragments 10&#x02013;16 in green in <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>c). Fragment ions with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 260.1396, 372.2032, 484.2668, and 596.3304 arise from sequential <italic toggle="yes">b<sub>x</sub>-y<sub>z</sub></italic> fragmentation steps and represent phenylalanine connected to increasing numbers of piperazate residues, whereas the remaining ions (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 232.1445, 456.2719, and 568.3356) are associated with a subsequent CO loss step.</p><p>It is interesting to note that no hydroxylation can be inferred from the seventeen fragments discussed above, confirming that the hydroxylation in compound <bold>1</bold> must reside in the remaining amino acid, i.e., isoleucine. This is confirmed by the presence of four fragments that contain a hydroxyl-isoleucine residue (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 214.1551, 242.1500, 347.1841, and 354.21366, fragments 17&#x02013;20 in red in <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>d), all of which resulted from similar fragmentation steps, as discussed for the other ions (sequential <italic toggle="yes">b<sub>x</sub>-y<sub>z</sub></italic> fragmentation and CO loss). Finally, the hydroxylation of compound <bold>1</bold> and the hypothesis of a hydroxylated isoleucine in its structure are further confirmed by the presence of four fragment ions seemingly resulting from the neutral loss of H<sub>2</sub>O (fragments 21&#x02013;24 in orange in <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>e). The fragment ion with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 707.3989 is the result of water loss from the [M+H]<sup>+</sup> adduct and can generate the ion itself with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 679.4040 from CO loss. The two other fragment ions (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 196.1447 and 224.1394) would come from the loss of water from the previously mentioned isoleucine-bearing fragments <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 214.1551 and 242.1500, respectively.</p></sec><sec id="sec2dot2dot2-ijms-24-01114"><title>2.2.2. Structure Elucidation by NMR Spectroscopy</title><p>Finally, nuclear magnetic resonance (NMR) was performed in order to confirm the predicted and MS/MS-deduced structure of compound <bold>1</bold>. Indeed, even though we can confidently propose the presence of a hydroxy-leucine residue in the structure of compound <bold>1</bold>, the MS/MS information alone does not allow to specify the position of the hydroxyl group in this residue. The fragment structures proposed in <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>d assume a hydroxylation on the amide nitrogen of isoleucine, which can only be confirmed by NMR. Multiple media were tested (OSMAC approach [<xref rid="B42-ijms-24-01114" ref-type="bibr">42</xref>] and known elicitors of secondary metabolite production in <italic toggle="yes">Streptomyces</italic> spp. [<xref rid="B43-ijms-24-01114" ref-type="bibr">43</xref>,<xref rid="B44-ijms-24-01114" ref-type="bibr">44</xref>,<xref rid="B45-ijms-24-01114" ref-type="bibr">45</xref>]) to assess the optimal culture conditions for compound <bold>1</bold> production in order to obtain sufficient material for NMR analysis. An analysis of the metabolite profiles showed that the solid ISP1 medium supplemented with N-acetyl-D-glucosamine 25 mM led to the best production yield of compound <bold>1</bold> (not shown). The dried ethyl-acetate full extract of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> was processed using the &#x000c4;KTA liquid chromatography purification system, followed by semi-preparative HPLC (SP-HPLC) purification, which resulted in 2.15 mg of a pale-yellow-white powder from ~0.5 L of solid culture. UPLC-HRMS/MS revealed that this fraction contained two compounds with similar molecular weights, the most intense molecular ion peak being compound <bold>1</bold> (<italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of 725.4092), and a second molecular ion peak with an <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of 723.3935 (compound <bold>2</bold>). This <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> value suggests that compound <bold>2</bold> is a dehydrogenated derivative of compound <bold>1</bold> that possibly contains a dehydro-Piz moiety, as was described previously for antrimycins [<xref rid="B46-ijms-24-01114" ref-type="bibr">46</xref>]. This hypothesis was confirmed by <sup>1</sup>H NMR results (see below) and by HRMS/MS analysis (see the following section on the structural diversity of lunaemycins).</p><p>The semi-purified powder containing compound <bold>1</bold> and minor amount of compound <bold>2</bold> was submitted to &#x000b9;H NMR (700MHz), &#x000b9;&#x000b3;C NMR (176 MHz) as well as 2D NMR (COSY, HMBC, and HSQC). 1D- and 2D NMR data were analyzed with MestReNova V.14 and allowed to confirm the chemical structure predicted by the in silico analysis of BGC 28a and deduced from the MS/MS fragmentation pattern. <xref rid="ijms-24-01114-t002" ref-type="table">Table 2</xref> shows the structure and NMR assignment proposed for compounds <bold>1</bold> and <bold>2</bold> (<xref rid="ijms-24-01114-f005" ref-type="fig">Figure 5</xref>a,b and <xref rid="app1-ijms-24-01114" ref-type="app">Supplementary Figures S2&#x02013;S6</xref>); however, the overlapping signals did not allow a complete structural assignment, as multiplicities and integrations were not unambiguously characterized.</p><p>Considering the chemical shifts observed in the <sup>1</sup>H and <sup>13</sup>C NMR spectra, signature signals typical of cyclopeptides were observed, revealing peptide bonds between amino acid residues with no amino or carboxy interruption of the amino acid sequence. <sup>1</sup>H NMR data revealed the presence of the six &#x003b1; hydrogens of the hexapeptide core between &#x003b4; 4.8 and &#x003b4; 5.8 that can be attributed to compound <bold>1</bold> (&#x003b4; 5.82&#x02013;5.76 for the Ile; &#x003b4; 5.36&#x02013;5.28 for the Phe; &#x003b4; 4.92&#x02013;4.84, 5.39, 5.45, and 5.75 for the Piz residues), and compound <bold>2</bold> (&#x003b4; 5.96 for the Ile; &#x003b4; 5.68 for the Phe; &#x003b4; 4.92&#x02013;4.84, 5.01, 5.36&#x02013;5.28, and 5.67 for the Piz residues). Further confirmation comes from the <sup>13</sup>C-NMR signals between &#x003b4; 170.3 and &#x003b4; 174.1, attributed to the peptide carbonyl groups (C-6, C-13, C-19, C-25, C-31, C-41), and between &#x003b4; 46.7 and &#x003b4; 56.4, attributed to the &#x003b1; carbons (C-2, C-12, C-18, C-24, C-30, C-33).</p><p>Based on previously published data [<xref rid="B47-ijms-24-01114" ref-type="bibr">47</xref>], a series of multiplets between &#x003b4; 1.2 and &#x003b4; 2.3 in the <sup>1</sup>H NMR spectra can be attributed the eight &#x003b2;- and &#x003b3;-methylene groups from the piperazate residues present in the structure of compound <bold>1</bold> (C-10, C-11, C-16, C-17, C-22, C-23, C-28, and C-29). Additionally, a series of <sup>13</sup>C NMR signals between &#x003b4; 18.4 and &#x003b4; 26.2 can be attributed to those same methylene groups. Similarly, the four &#x003b4;-methylene groups (C-9, C-15, C-21, and C-27) can be correlated to the <sup>1</sup>H NMR signals between &#x003b4; 2.9 and &#x003b4; 3.1 and to the <sup>13</sup>C NMR signals between &#x003b4; 46.9 and &#x003b4; 47.3. Interestingly, a signal at &#x003b4; 6.91 (d, <italic toggle="yes">J</italic> = 3.7 Hz, <sup>1</sup>H for compound <bold>2</bold>) in the <sup>1</sup>H NMR spectra, which is correlated on the HSQC to the <sup>13</sup>C NMR signal at &#x003b4; 142.9, can be attributed to a methylene hydrogen of an imine group. This observation supports the hypothesis of a replacement of a piperazate residue by a dehydro-piperazate in compound <bold>2</bold>.</p><p>The presence of phenylalanine and isoleucine residues in the structure of compounds <bold>1</bold> and <bold>2</bold> is clearly detectable from the results of NMR experiments (<xref rid="ijms-24-01114-t002" ref-type="table">Table 2</xref>). The six aromatic carbons (C-35 to C-40) of the phenylalanine&#x02019;s benzene ring were observed at &#x003b4; 137.7 (quaternary carbon C-35); &#x003b4; 128.4 (two meta carbons, C-37 and C-39); 129.7, (two ortho carbons, C-36 and C-40); and &#x003b4; 126.6 (the para carbon C-38). Also, the five aromatic hydrogens corresponding to this benzene ring were observed in <sup>1</sup>H NMR spectra between &#x003b4; 7.1 and &#x003b4; 7.2. The two hydrogens at meta position (linked to C-37 and C-39) were attributed to the signal at &#x003b4; 7.24 and could be discerned from the three hydrogens on ortho (linked to C-36 and C-40) and para (linked to C-38), seen at &#x003b4; 7.2&#x02013;7.14. As for the non-aromatic carbons in those residues, we were able to attribute <sup>13</sup>C signals to the two methylenes (&#x003b4; 25.2 for C-4 from the Ile and &#x003b4; 37.7 for C-34 from the Phe), to the tertiary carbon C-3 from the Ile (&#x003b4; 32.8), and to the two methyls, C-5 and C-7, from the Ile (&#x003b4; 11.1 and 15.5, respectively). The upfield region of the <sup>1</sup>H NMR spectrum shows signals corresponding to the non-aromatic hydrogens of the minor (<bold>2</bold>) and major (<bold>1</bold>) compounds of the sample analyzed by NMR. The methylene hydrogen of isoleucine, linked to C-4, can be attributed to &#x003b4; 1.02&#x02013;0.94, while the methylene hydrogens of phenylalanine, linked to C-34, were attributed to &#x003b4; 2.93&#x02013;2.86 and 2.77&#x02013;2.67. For the isoleucine, the hydrogen on C-3 was attributed to peaks between &#x003b4; 2.12&#x02013;2.03, and the methyl hydrogens linked to C-5 and C-7 were attributed to &#x003b4; 0.82&#x02013;0.76 and &#x003b4; 0.84, respectively.</p><p>The observation of the non-substituted s-butyl group of isoleucine indicates that hydroxylation of <bold>1</bold> is not localized at its side chain, suggesting that the hydroxylation should take place at the amide nitrogen. Additionally, 2D NMR COSY and <sup>1</sup>H-<sup>13</sup>C HMBC correlations, shown in <xref rid="ijms-24-01114-f005" ref-type="fig">Figure 5</xref>c and highlighting proton-proton and proton-carbon correlations respectively, further supported this conclusion. Another key observation is the presence of a single HMBC correlation between an alpha NH <sup>1</sup>H NMR signal at &#x003b4; 8.27 (attributed to phenylalanine&#x02019;s NH) and an alpha carbonyl <sup>13</sup>C NMR signal at &#x003b4; 172.7 (attributed to the neighboring piperazate carbonyl). Those observations allowed us to further confirm the N-hydroxylated structure previously proposed for Lunaemycin A.</p><p>In conclusion, combined in silico, HRMS/MS, and NMR analyses demonstrated that the main product of BGC 28a, compound <bold>1</bold>, is a cyclic hexapeptide of a mass of 724.4019 Da and the molecular formula C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>7</sub>, corresponding to the cyclized amino acid sequence D-Phe-OH-L-Ile-D-Piz-L-Piz-D-Piz-L-Piz. We have interrogated StreptomeDB 3.0 [<xref rid="B48-ijms-24-01114" ref-type="bibr">48</xref>] and The Natural Products Atlas 2.0 [<xref rid="B49-ijms-24-01114" ref-type="bibr">49</xref>] databases and found no natural compounds with neither identical molecular formula, monoisotopic mass, nor molecular weight. Interrogation of databases with broader chemical compounds (NIST, Pubchem, and Chemspider) identified &#x02018;SCHEMBL12568990&#x02032; (Substance SID: 237623651; Compound CID: 53234730 in the Pubchem database) retrieved from patent US-2011136752-A1 [<xref rid="B50-ijms-24-01114" ref-type="bibr">50</xref>], as the closest match of compound <bold>1</bold>, sharing the same mass, same molecular formula, and same proposed structure. We decided to call compound <bold>1</bold> lunaemycin A, with the Latin prefix lunae- (L. gen. n. lunae, of the moon) referring to the moonmilk speleothems where <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> was originally isolated and the suffix -mycin, which refers to antibiotic compounds derived from bacteria with fungus-like structure such as <italic toggle="yes">Streptomyces</italic>. The antibiotic activity of lunaemycins A and lunaemycin-related compounds will be described in <xref rid="sec2dot4-ijms-24-01114" ref-type="sec">Section 2.4</xref>.</p></sec></sec><sec id="sec2dot3-ijms-24-01114"><title>2.3. Structural Diversity of Lunaemycins</title><p>The comparative metabolomic study of metabolites with masses ranging between 700 and 800 Da (<xref rid="ijms-24-01114-f002" ref-type="fig">Figure 2</xref>b) suggested a broad diversity of lunaemycin-derived molecules produced by <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains containing pSLUN1a. Using the MS/MS data, we explored this diversity via global natural products social molecular networking (GNPS) as performed previously [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>]. One constellation comprises 42 nodes associated with compounds only produced by the two selected <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains that possess BGC 28a (MM37 and MM109<sup>T</sup>) and includes the ion at <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 725 corresponding lunaemycin A (<xref rid="ijms-24-01114-f006" ref-type="fig">Figure 6</xref>).</p><p><xref rid="ijms-24-01114-f007" ref-type="fig">Figure 7</xref> presents the detection of the most abundant compounds identified as lunaemycin derivatives produced by <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup>, as well as their HRMS spectra and their deduced molecular formula. Comparison of the MS/MS spectra allowed us to identify the position of the chemical modification(s) for 14 of these molecules compared to lunaemycin A (<xref rid="app1-ijms-24-01114" ref-type="app">Figures S7&#x02013;S20</xref>, <xref rid="ijms-24-01114-t003" ref-type="table">Table 3</xref>), whereas other five lunaemycin derivatives were produced in too weak amounts for proper analysis. <xref rid="ijms-24-01114-t003" ref-type="table">Table 3</xref> lists all compounds clustering in the constellations of lunaemycins, their proposed names, retention times, <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> signals, and their molecular formulas.</p><p>The HRMS/MS-based identification of the amino acid building-blocks composing the 15 lunaemycins is detailed in <xref rid="app1-ijms-24-01114" ref-type="app">supplementary Figures S7&#x02013;S20</xref>. Eight lunaemycins possess at least one dehydrogenated-Piz (dh-Piz, corresponding to the neutral loss of 110.5) instead of a classical Piz. More precisely, if we consider the linear sequence of Lunaemycin A as Hydroxy-Ile-Piz<sub>1</sub>-Piz<sub>2</sub>-Piz<sub>3</sub>-Piz<sub>4</sub>-Phe, Piz<sub>1</sub> is replaced by a dh-Piz in lunaemycin E1 (<bold>5a</bold>); Piz<sub>2</sub> is replaced by a dh-Piz in lunaemycins B1 (<bold>2a</bold>), C1 (<bold>3a</bold>), and J1 (<bold>10a</bold>); Piz<sub>3</sub> is replaced by a dh-Piz in lunaemycins B1(<bold>2a</bold>), C1 (<bold>3a</bold>), C2 (<bold>3b</bold>), E1 (<bold>5a</bold>), and J3 (<bold>10c</bold>); and finally, Piz<sub>4</sub> is replaced by a dh-Piz in lunaemycin C1 (<bold>3a</bold>). Only lunaemycin F (<bold>6</bold>) presents the hydroxy-Piz residue (HO-Piz, corresponding to the neutral loss of 128.09) at the position of Piz<sub>3</sub>. Five lunaemycins present the hydroxydehydro-Piz residue (HO-dh-Piz, corresponding to the neutral loss of 126.05) at the position of Piz<sub>4</sub> (lunaemycins D (<bold>4</bold>), E1 (<bold>5a</bold>), E2 (<bold>5b</bold>), G (<bold>7</bold>), and H (<bold>8</bold>). Finally, the HO-Ile is replaced by a dihydroxy-Ile (DIHO-Ile, corresponding to the neutral loss of 145.08) in lunaemycins G (<bold>7</bold>) and H (<bold>8</bold>), by an hydroxyl-Valine (HO-Val, corresponding to the neutral loss of 115.06) in lunaemycins I (<bold>9</bold>), J2 (<bold>10b</bold>), and J3 (<bold>10c</bold>), and by an Ile (corresponding to the neutral loss of 113.08) in lunaemycin J1 (<bold>10a</bold>).</p></sec><sec id="sec2dot4-ijms-24-01114"><title>2.4. Antibacterial Activity of Lunaemycins</title><p>Molecules produced by known BGCs closest to the <italic toggle="yes">lun</italic> cluster (himastatins, stenothricins, kutznerides, and aurantimycins) possess antimicrobial activities suggesting that lunaemycins could possibly display similar biological activities. Moreover, amongst the genes of the <italic toggle="yes">lun</italic> BGC, BLAST analyses also suggest that lunaemycins are likely to possess antibacterial and/or anti-proliferative activities. For instance, <italic toggle="yes">lun9</italic> and <italic toggle="yes">lun10</italic> encode for an efflux pump and its associated TetR-family transcriptional regulator, respectively, and whose homologues in other BGCs play a role in self-resistance of the producing organism. In addition, <italic toggle="yes">lun25</italic> and <italic toggle="yes">lun26</italic> and their closest homologues in the BGCs of aurantimycins (ArtJ and ArtK) and the polyoxipeptins (PlyJ and PlyK), encode for an ABC transporter system belonging to the DrrA-DrrB family also conferring self-resistance to the producers [<xref rid="B51-ijms-24-01114" ref-type="bibr">51</xref>].</p><p>Antibacterial activity of lunaemycins A, B1, and D (0.1 mg/mL, ~13.5&#x02013;14 mM) was first performed via agar-diffusion assays which showed significant direct-acting activity on all tested Gram-positive bacteria except on <italic toggle="yes">Enterococcus hirae</italic> (though a small zone of growth inhibition is observed at the periphery of the disc suggesting more susceptibility to lunaemycins compared to gentamicin 0.1 mg/mL used as positive control) (<xref rid="ijms-24-01114-f008" ref-type="fig">Figure 8</xref>). In contrast, no growth inhibition was reported on Gram-negative bacteria (<xref rid="ijms-24-01114-f008" ref-type="fig">Figure 8</xref>). Overall, similar antibacterial activities could be observed for lunaemycins A and B1, whereas lunaemycin D showed weaker growth inhibiting activities.</p><p>Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values were determined with pure lunaemycin A. The potent direct-acting activity observed in agar diffusion assays was confirmed, with MIC values ranging 0.12&#x02013;0.25 &#x000b5;g/mL on type strains and, more interestingly, also on clinical isolates showing various resistance phenotypes (<xref rid="ijms-24-01114-t004" ref-type="table">Table 4</xref>). The MBC values were comprised between 0.25 and 8 &#x000b5;g/mL. Interestingly, the MBC values obtained with some antibiotic resistant clinical isolates, especially those showing resistance to methicillin, vancomycin, or linezolid, were overall lower (from 0.25 to 2 &#x000b5;g/mL) than that of other strains, indicating a potent bactericidal activity of luneamycin A for these strains. As largely reported in the literature (e. g., references [<xref rid="B52-ijms-24-01114" ref-type="bibr">52</xref>,<xref rid="B53-ijms-24-01114" ref-type="bibr">53</xref>]), some of these resistance mechanisms are associated with significant biological or fitness cost, potentially explaining the lower MBC values measured with these strains. Expectedly, no activity could be observed on both susceptible and resistant Gram-negative isolates, as previously observed via the agar-diffusion assays.</p></sec></sec><sec id="sec3-ijms-24-01114"><title>3. Materials and Methods</title><sec id="sec3dot1-ijms-24-01114"><title>3.1. Bacterial Strains and Culture Conditions</title><p>All bacterial strains used in this study are listed in <xref rid="ijms-24-01114-t005" ref-type="table">Table 5</xref>. The archetype strain <italic toggle="yes">Streptomyces lunaelactis</italic> MM109<sup>T</sup> [<xref rid="B20-ijms-24-01114" ref-type="bibr">20</xref>,<xref rid="B21-ijms-24-01114" ref-type="bibr">21</xref>] and all other <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains used in this study were isolated from moonmilk deposits of the cave &#x02018;la grotte des collemboles&#x02019; (Comblain-au-Pont, Belgium) [<xref rid="B9-ijms-24-01114" ref-type="bibr">9</xref>,<xref rid="B10-ijms-24-01114" ref-type="bibr">10</xref>]. <italic toggle="yes">Streptomyces</italic> spores and mycelium stocks were prepared as described in [<xref rid="B54-ijms-24-01114" ref-type="bibr">54</xref>]. Cultivation media were prepared as described in [<xref rid="B54-ijms-24-01114" ref-type="bibr">54</xref>], and inoculated plates were incubated for a week at 28 &#x000b0;C.</p></sec><sec id="sec3dot2-ijms-24-01114"><title>3.2. Bioinformatics and In Silico Analyzes</title><p>Mining for BGC in pSLUN1a (NZ_CP026305.1) and identification of closest homologous genes in known BGCs in MiBIG database [<xref rid="B27-ijms-24-01114" ref-type="bibr">27</xref>] were performed with antiSMASH [<xref rid="B55-ijms-24-01114" ref-type="bibr">55</xref>]. Sequence of linear plasmid pSLUN1b can be accessed from (<uri xlink:href="https://www.ncbi.nlm.nih.gov/search/all/?term=JABSUF010000009">https://www.ncbi.nlm.nih.gov/search/all/?term=JABSUF010000009</uri>, accessed on 17 June 2020). Prediction of amino acid building blocks recruited by adenylation domains was performed with SANDPUMA [<xref rid="B39-ijms-24-01114" ref-type="bibr">39</xref>] and NRPSpredictor2 [<xref rid="B56-ijms-24-01114" ref-type="bibr">56</xref>]. Visualization of the molecular network (metabolite diversity and relatedness)) was performed via the Global Natural Products Social Molecular Networking website (GNPS, <uri xlink:href="https://gnps.ucsd.edu/">https://gnps.ucsd.edu/</uri>, accessed on 17 June 2020) from the tandem mass (MS/MS) spectrometry data obtained from the culture extracts od the different S. <italic toggle="yes">lunaelactis</italic> strains as previously described [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>]. 1D- and 2D NMR data were analyzed with MestreNova V.14 (<uri xlink:href="https://mestrelab.com/download_file/mnova-14-0-0/">https://mestrelab.com/download_file/mnova-14-0-0/</uri>, accessed on 17 June 2020).</p></sec><sec id="sec3dot3-ijms-24-01114"><title>3.3. Compound Identification by Ultra-Performance Liquid Chromatography&#x02013;Tandem Mass Spectrometry (UPLC&#x02013;MS/MS)</title><p>Solid media inoculated with <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> were cut into small pieces and mixed overnight in agitator with an equal volume of ethyl acetate to extract metabolites. After centrifugation at 4000 rpm for 20 min, the supernatant was evaporated to dryness by a rotavapor<sup>&#x000ae;</sup> (IKA RV10 digital, VWR, Radnor, PA, USA) at 25 &#x000b0;C under 210 rpm and suspended in 2 mL of acetonitrile. Extracts were analyzed by Ultra-Performance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC&#x02013;HRMS) and by Ultra-Performance Liquid Chromatography&#x02013;Tandem Mass Spectrometry (UPLC&#x02013;MS/MS). Lunaemycins were identified according to their exact mass, the isotopic pattern, their MS/MS spectrum of the molecular ion HCD fragmentation, and the UV-VIS absorbance spectra. The detailed protocols for lunaemycins extraction and purification are detailed in Point 3.4. and <xref rid="app2-ijms-24-01114" ref-type="app">Appendix A</xref>, <xref rid="app2-ijms-24-01114" ref-type="app">Appendix B</xref>, <xref rid="app2-ijms-24-01114" ref-type="app">Appendix C</xref>, <xref rid="app2-ijms-24-01114" ref-type="app">Appendix D</xref> and <xref rid="app2-ijms-24-01114" ref-type="app">Appendix E</xref></p></sec><sec id="sec3dot4-ijms-24-01114"><title>3.4. Nuclear Magnetic Resonance (NMR)</title><p>The production and purification of lunaemycins was performed as follows: the ethyl acetate extract of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> grown on 25 agar plates of ISP1 + GlcNAc (~500 mL volume) was dried with rotary evaporator (Rotavapor<sup>&#x000ae;</sup> R-100) which allowed to obtain 126 mg of a pale yellow powder, re-dissolved in 60 mL of an acetonitrile/water (MilliQ filtered) (10:3, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) solution, and fractioned on a C18 LC column (Phenomenex) using an &#x000c4;KTA&#x02122; purification system. Metabolite elution was performed by using a gradient of increasing concentration of acetonitrile (LC method, <xref rid="app2-ijms-24-01114" ref-type="app">Appendix A</xref>), and each of the 90 fractions were analyzed by HPLC (HPLC method, <xref rid="app3-ijms-24-01114" ref-type="app">Appendix B</xref>) to detect peaks corresponding to lunaemycins. Fractions containing the compounds of interest (fractions 35, 36, and 37 to 41) were subjected to a second round of purification using semi-preparative HPLC (SP-HPLC method, <xref rid="app4-ijms-24-01114" ref-type="app">Appendix C</xref>). Fractions 37 to 41 were pooled, and the volume of each fraction was reduced to 2 mL by evaporation (under gas flow), which served for twenty semi-preparative HPLC injections with 100 &#x000b5;L of each fraction. From fraction 35, we generated 21 sub-fractions among which 4 of them contain lunaemycin D (<xref rid="ijms-24-01114-t003" ref-type="table">Table 3</xref>) as subsequent UPLC-HRMS analysis (UPLC Method <xref rid="app5-ijms-24-01114" ref-type="app">Appendix D</xref>, and the MS Method, <xref rid="app6-ijms-24-01114" ref-type="app">Appendix E</xref>) identified the molecular ion species of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 739.39 [M+H]<sup>+</sup>. Fraction 36 generated 19 sub-fractions, among which sub-fractions 3 to 5 contain lunaemycin D (previously identified in fraction 35), and sub-fractions 17 to 19 contain lunaemycin B1, as confirmed by UPLC-HRMS analysis that detected the molecular ion species of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 723.40 [M+H]<sup>+</sup>. Finally, the pooled fractions 37&#x02013;41 generated 40 sub-fractions (SP-HPLC method, <xref rid="app4-ijms-24-01114" ref-type="app">Appendix C</xref>), among which sub-fractions 23 to 28 mainly contain lunaemycin A (ion species of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 725.41 [M+H]<sup>+</sup>, see <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>a), and lower amounts of lunaemycins B1/B2 (ion species of <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 723.40 [M+H]<sup>+</sup>, see <xref rid="ijms-24-01114-f004" ref-type="fig">Figure 4</xref>a). The fractions containing a single chromatographic peak were pooled and evaporated under continuous gas flow and resuspended in 1 mL of water/acetonitrile (1/9, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) solution and diluted to reach a concentration of 0.1 mg/mL for subsequent antibacterial assays (see point 4.5 below).</p><p>The pure dried extract mainly containing lunaemycins A (compound 1) was dissolved in 250 &#x000b5;L of hexadeuterodimethylsulfoxide (DMSO-d<sub>6</sub>) containing 1% (<italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) of tetramethylsilane (TMS) as a reference (Sigma-Aldrich, St. Louis, MO, USA) and transferred in a 3 mm NMR tube (103.5 mm long, Bruker). NMR spectra were acquired using a Bruker Avance NEO 700 MHz spectrometer equipped with a cryoprobe and Bruker&#x02019;s TopSpin 3.5 software package, in order to perform <sup>1</sup>H, <sup>13</sup>C (APT), COSY, <sup>1</sup>H-<sup>13</sup>C HMBC, and <sup>1</sup>H-<sup>13</sup>C HSQC experiments (standard Bruker parameters), and data were interpretated using the MestreNova V.14 software. Sample temperatures were controlled with the variable-temperature unit of the instrument.</p></sec><sec id="sec3dot5-ijms-24-01114"><title>3.5. Antibacterial Assays</title><p>Pure lunaemycins A, B1, and D were obtained as described above in point 4.4. Agar-diffusion tests were implemented as described previously [<xref rid="B24-ijms-24-01114" ref-type="bibr">24</xref>]. Briefly, few microliters of an overnight culture (10 &#x000b5;L of the bacterial stock spread on the solid LB or BH media) were used to make bacterial suspensions with standardized turbidity (OD600 between 0.08 and 0.1, corresponding to a 0.5 McFarland turbidity standard). A total of 100 &#x000b5;L of the standardized bacterial suspension were then inoculated on solid LB or BH media, and 3 mm thick Whatman<sup>&#x000ae;</sup> papers discs (Sigma-Aldrich, St. Louis, MO, USA) containing 10 &#x000b5;L (2 &#x000d7; 5 &#x000b5;L) of antibiotics are placed on the freshly inoculated solid medium. After overnight incubation at 37 &#x000b0;C, the antibacterial activity was evaluated by measuring the diameter of growth inhibition. Control conditions were performed using 100 &#x000b5;g/mL gentamicin as a positive control (corresponding to 1 &#x000b5;g of gentamicin placed on the positive control disc), and acetonitrile, DMSO or water as a negative control. Additional antibacterial susceptiblity assays were performed at the High-Throughput Screening and Protein Engineering platform (HiProtEn, Dipartimento di Biotecnologie Mediche&#x02014;Universit&#x000e0; di Siena). Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values were determined in Mueller-Hinton broth, as recommended by CLSI (document M07-A10, 2015 [<xref rid="B57-ijms-24-01114" ref-type="bibr">57</xref>]) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST document &#x0201c;Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents&#x0201d;, 2000 [<xref rid="B58-ijms-24-01114" ref-type="bibr">58</xref>]) on reference (type) strains and clinical isolates as indicated (<xref rid="ijms-24-01114-t005" ref-type="table">Table 5</xref>).</p></sec></sec><sec sec-type="conclusions" id="sec4-ijms-24-01114"><title>4. Conclusions</title><p>Herein, we report the discovery and structural elucidation of lunaemycins: new, cyclic hexapeptide antibiotics only produced by <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> species that possess the linear plasmid pSLUN1a. The potent antibacterial activity of lunaemycins against antibiotic resistant Gram-positive bacteria may in part explain how <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains have found their own place in extremely oligotrophic and competitive environments such as moonmilk deposits. Next to the proposed structure of 15 lunaemycin derivatives, we also propose the biosynthetic pathway for lunaemycin A production, the main compound of the <italic toggle="yes">lun</italic> BGC of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> (<xref rid="ijms-24-01114-f009" ref-type="fig">Figure 9</xref>).</p><p>Our work provides a good example in which a deep in silico analysis of genes that compose a BGC combined with an exhaustive literature overview of homologous genes allowed us to maximize the accuracy of the predicted structure of a cryptic compound. This in silico approach highly facilitated the comparative mass spectrometry analysis by guiding the examination on a limited series of ions that possessed the appropriate fragmentation tags. Next to core biosynthetic genes, the <italic toggle="yes">lun</italic> BGC also provides an interesting case where genes required for the synthesis of the building block piperazic acid from ornithine are also present within the BGC itself, and even also the genes that convert the glutamate and glutamine precursors to ornithine. Such a situation was previously observed, notably in the BGC for quinichelin biosynthesis [<xref rid="B59-ijms-24-01114" ref-type="bibr">59</xref>], and in many NRPS BGCs that necessitate Piz as building block [<xref rid="B37-ijms-24-01114" ref-type="bibr">37</xref>]. This inclusion of genes/enzymes of metabolic pathways of primary metabolism within a BGC is most likely mandatory to provide sufficient building blocks at the proper timing of specialized metabolite production.</p><p>Another main take-home message of our work relates to the use of multiple strains of the same species to facilitate the correlation between the genetic material associated with the biosynthesis of natural compounds. The current tendency in strain prioritization is instead to try to exclude from a collection the multiple strains that belong to the same species in order to avoid the identification of the same bioactive molecules [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>]. Here, we showed how strain redundancy instead facilitated our work, even avoiding the necessity to generate null mutants to link a BGC to its natural product. This is particularly interesting when a BGC is present on a linear plasmid whose presence in multiple copies complicates gene inactivation (about three copies for pSLUN1a in <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> [<xref rid="B21-ijms-24-01114" ref-type="bibr">21</xref>]). Our attempts to delete genes of BGC 28a have been unsuccessful so far. We are currently applying the same strategy to identify and assess the biological activity of the cryptic products of BGC 28b found in the linear plasmid pSLUN1b only present in the second subgroup of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>].</p></sec></body><back><ack><title>Acknowledgments</title><p>We are grateful to D. Adam, B. Deflandre, M. Maciejewska, E. Tenconi, S. Anderssen, and N. Stulanovic at the Streptomyces Genetics and Development group, and everyone at HEDERA-22 for fruitful discussions and technical support.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-ijms-24-01114"><title>Supplementary Materials</title><p>The supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/ijms24021114/s1">https://www.mdpi.com/article/10.3390/ijms24021114/s1</uri>.</p><supplementary-material id="ijms-24-01114-s001" position="float" content-type="local-data"><media xlink:href="ijms-24-01114-s001.zip"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, L.M. and S.R.; methodology, L.M.; software, A.N., L.C.D.R., G.M. and M.F.; validation, L.M., A.N., L.C.D.R., B.P., M.F. and S.R.; formal analysis, L.M. and A.N.; investigation, L.M., A.N., L.C.D.R., D.T., F.S. and D.B.; resources, G.M., M.F. and S.R.; Data curation, L.M., A.N., L.C.D.R., G.M., M.F. and S.R.; writing&#x02014;original draft preparation, L.M. and S.R.; writing&#x02014;review and editing, L.M., L.C.D.R., D.T., M.F., D.B., J.-D.D. and S.R.; visualization, L.M., A.N., L.C.D.R. and S.R.; supervision, S.R.; project administration, S.R.; funding acquisition, S.R. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The Molecular Networking job in GNPS can be found at <uri xlink:href="https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=84ea45db68814c94a3b2bad9c26dd807">https://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=84ea45db68814c94a3b2bad9c26dd807</uri>, accessed on 14 October 2019.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><app-group><app id="app2-ijms-24-01114"><title>Appendix A. LC Method</title><p>After equilibration of the stationary phase in 100 mL of a 30% acetonitrile solution, the full extract (diluted in 60 mL of a 30% acetonitrile solution) was loaded on the column, followed by five successive elution steps with 60 mL of a 40, 50, 66, 80, and finally 100% of an acetonitrile solution. In total, 90 fractions were collected (fractions of 5 mL from the full extract injection until the end of the 50% acetonitrile elution step and in the last elution step at 100% of acetonitrile; fractions of 3 mL fractions were collected during the elution steps with 66 and 80% of acetonitrile solution). This method was applied on a GE AKTA Prime Plus Liquid Chromatography System with a bulk of Sepra&#x02122; C18-E column (Phenomenex, 50 &#x003bc;m, 65 &#x000c5;) manually packed in a XK16 bulk (Pharmacia Biotech).</p></app><app id="app3-ijms-24-01114"><title>Appendix B. HPLC Method</title><p>The HPLC system (HPLC Alliance, Waters) used a reversed phase Luna<sup>&#x000ae;</sup> Omega PS C18 column (Phenomenex, 2.1mm by 150 mm, 5 &#x003bc;m particle size, 100-&#x000c5; pore size) column. Metabolites separation was performed using a step gradient system of 0.1% FA in 0.22 &#x003bc;m filtrated milliQ H<sub>2</sub>O (solvent A) and acetonitrile (Barker; HPLC Far UV grade) (solvent B), as follows: after a 2 min equilibration, the gradient started from 5% and went to 100% of B in 80 min, stayed at 100% of B during 8 min, decreased to 5% of B in 8 min and finally pre-equilibrated the system for 2 min; flow rate: 0.5 mL/min; column temperature of 40 &#x000b0;C. 50 &#x000b5;L of pre-purified fractions were injected and single UV-Vis absorbance were measured at 195 and 220 nm. Full UV-Vis absorbance scans were also recorded for all analyses (from 190 to 800 nm).</p></app><app id="app4-ijms-24-01114"><title>Appendix C. SP-HPLC Method</title><p>SP-HPLC column Luna<sup>&#x000ae;</sup> Omega PS C18 column (Phenomenex, 21.2 mm by 50 mm, 5 &#x003bc;m particle size, 100-&#x000c5; pore size) allowed accurate purification of lunaemycins using agradient system of 0.1% FA in 0.22 &#x000b5;m filtrated milliQ H<sub>2</sub>O (solvent A) and acetonitrile (Barker; HPLC Far UV grade) (solvent B), as follows: after a 2 min equilibration, the gradient started from 50% and went to 70% of B in 18 min, stayed at 70% of B during 8 min, decreased to 50% of B in 1 min and finally pre-equilibrated the system for 1 min; flow rate: 3.5 mL/min. 50 &#x000b5;L of pre-purified fractions were injected and single UV-Vis absorbance were measured at 195 and 220 nm. Full UV-Vis absorbance scans were also recorded for all analyses (from 190 to 800 nm).</p></app><app id="app5-ijms-24-01114"><title>Appendix D. UPLC Method</title><p>RP-HPLC column Luna<sup>&#x000ae;</sup> Omega PS C18 column (Phenomenex, 2.1 mm by 150 mm, 5 &#x003bc;m particle size, 100-&#x000c5; pore size) allowed the separation of metabolites using a gradient system of 0.1% FA in 0.22 &#x000b5;m filtrated milliQ H<sub>2</sub>O (solvent A) and acetonitrile (Barker; HPLC Far UV grade) (solvent B), as follows: after 2 min of equilibration of the column, the gradient started from 5% and went to 100% of B in 23 min, stayed at 100% of B during 2 min, decreased to 5% of B in 1 min and finally equilibrated the system for 2 min; flow rate: 0.4 mL/min; column temperature 40 &#x000b0;C. 10 &#x000b5;L of each fraction were injected and absorbance was measured at 220 and 280 nm.</p></app><app id="app6-ijms-24-01114"><title>Appendix E. MS Method</title><p>All HRMS and HRMS/MS spectra were obtained using the same UPLC-HRMS/MS method. High-Resolution Electrospray Ionization Mass Spectrometry&#x02014;HRESIMS data were acquired on a Q Exactive Plus hybrid Quadrupole-Orbitrap mass spectrometer equipped with an electrospray ionization (ESI) source (Q Exactive Plus, Thermo Fisher Scientific, San Jose, CA, USA). Briefly, compounds were separated by reverse-phase chromatography using ultraperformance liquid chromatography (UPLC I-Class, Waters) as described in <xref rid="app5-ijms-24-01114" ref-type="app">Appendix D</xref>&#x02014;UPLC method. This chromatographic system was coupled to a Q Exactive Plus, operated in electrospray positive ion mode and programmed for data-dependent acquisitions. Survey scans were acquired at a mass-resolving power level of 140,000 FWHM (full width at half-maximum) from 100 to 1500 <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> (accumulation target, 1 &#x000d7; 10<sup>6</sup> ions or maximum inject time of 200 ms). The five ions showing the greatest intensity were then selected for tandem mass spectrometry (MS/MS) experiments by the use of higher-energy collision dissociation (HCD) fragmentation and stepped normalized collision energy (NCE) (21.2; 25; 28) within 2-atomic-mass-unit (amu) isolation window (resolution, 17,500; accumulation target, 1 &#x000d7; 10<sup>5</sup> ions or maximum inject time of 200 ms). Dynamic exclusion was enabled for 10 s. Data were analyzed using Xcalibur v2.2 (Thermo Fisher Scientific, San Jose, CA, USA). Each of the compounds was identified in accordance with its exact mass and isotope pattern, observation of the MS/MS spectra obtained by molecular ion fragmentation, and the UV-VIS absorbance.</p></app></app-group><ref-list><title>References</title><ref id="B1-ijms-24-01114"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barka</surname><given-names>E.A.</given-names></name>
<name><surname>Vatsa</surname><given-names>P.</given-names></name>
<name><surname>Sanchez</surname><given-names>L.</given-names></name>
<name><surname>Gaveau-Vaillant</surname><given-names>N.</given-names></name>
<name><surname>Jacquard</surname><given-names>C.</given-names></name>
<name><surname>Klenk</surname><given-names>H.-P.</given-names></name>
<name><surname>Cl&#x000e9;ment</surname><given-names>C.</given-names></name>
<name><surname>Ouhdouch</surname><given-names>Y.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Taxonomy, Physiology, and Natural Products of Actinobacteria</article-title><source>Microbiol. Mol. Biol. Rev.</source><year>2015</year><volume>80</volume><fpage>1</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1128/MMBR.00019-15</pub-id><pub-id pub-id-type="pmid">26609051</pub-id></element-citation></ref><ref id="B2-ijms-24-01114"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Hopwood</surname><given-names>D.A.</given-names></name>
</person-group><source>Streptomyces in Nature and Medicine: The Antibiotic Makers</source><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, NY, USA</publisher-loc><year>2007</year><isbn>978-0-19-515066-7</isbn></element-citation></ref><ref id="B3-ijms-24-01114"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van der Meij</surname><given-names>A.</given-names></name>
<name><surname>Worsley</surname><given-names>S.F.</given-names></name>
<name><surname>Hutchings</surname><given-names>M.I.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Chemical Ecology of Antibiotic Production by Actinomycetes</article-title><source>FEMS Microbiol. Rev.</source><year>2017</year><volume>41</volume><fpage>392</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1093/femsre/fux005</pub-id><?supplied-pmid 28521336?><pub-id pub-id-type="pmid">28521336</pub-id></element-citation></ref><ref id="B4-ijms-24-01114"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hui</surname><given-names>M.L.-Y.</given-names></name>
<name><surname>Tan</surname><given-names>L.T.-H.</given-names></name>
<name><surname>Letchumanan</surname><given-names>V.</given-names></name>
<name><surname>He</surname><given-names>Y.-W.</given-names></name>
<name><surname>Fang</surname><given-names>C.-M.</given-names></name>
<name><surname>Chan</surname><given-names>K.-G.</given-names></name>
<name><surname>Law</surname><given-names>J.W.-F.</given-names></name>
<name><surname>Lee</surname><given-names>L.-H.</given-names></name>
</person-group><article-title>The Extremophilic Actinobacteria: From Microbes to Medicine</article-title><source>Antibiot. Basel Switz.</source><year>2021</year><volume>10</volume><elocation-id>682</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10060682</pub-id><?supplied-pmid 34201133?><pub-id pub-id-type="pmid">34201133</pub-id></element-citation></ref><ref id="B5-ijms-24-01114"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Axenov-Gibanov</surname><given-names>D.V.</given-names></name>
<name><surname>Voytsekhovskaya</surname><given-names>I.V.</given-names></name>
<name><surname>Tokovenko</surname><given-names>B.T.</given-names></name>
<name><surname>Protasov</surname><given-names>E.S.</given-names></name>
<name><surname>Gamaiunov</surname><given-names>S.V.</given-names></name>
<name><surname>Rebets</surname><given-names>Y.V.</given-names></name>
<name><surname>Luzhetskyy</surname><given-names>A.N.</given-names></name>
<name><surname>Timofeyev</surname><given-names>M.A.</given-names></name>
</person-group><article-title>Actinobacteria Isolated from an Underground Lake and Moonmilk Speleothem from the Biggest Conglomeratic Karstic Cave in Siberia as Sources of Novel Biologically Active Compounds</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149216</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149216</pub-id><pub-id pub-id-type="pmid">26901168</pub-id></element-citation></ref><ref id="B6-ijms-24-01114"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Ca&#x00142;usi&#x00144;ska</surname><given-names>M.</given-names></name>
<name><surname>Cornet</surname><given-names>L.</given-names></name>
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Pessi</surname><given-names>I.S.</given-names></name>
<name><surname>Malchair</surname><given-names>S.</given-names></name>
<name><surname>Delfosse</surname><given-names>P.</given-names></name>
<name><surname>Baurain</surname><given-names>D.</given-names></name>
<name><surname>Barton</surname><given-names>H.A.</given-names></name>
<name><surname>Carnol</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>High-Throughput Sequencing Analysis of the Actinobacterial Spatial Diversity in Moonmilk Deposits</article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>E27</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7020027</pub-id><?supplied-pmid 29561792?><pub-id pub-id-type="pmid">29561792</pub-id></element-citation></ref><ref id="B7-ijms-24-01114"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>S.</given-names></name>
<name><surname>Cho</surname><given-names>Y.-J.</given-names></name>
<name><surname>Jung</surname><given-names>D.</given-names></name>
<name><surname>Jo</surname><given-names>K.</given-names></name>
<name><surname>Lee</surname><given-names>J.-S.</given-names></name>
</person-group><article-title>Microbial Diversity of Baeg-Nyong Cave and Characterization of the Antibiotics Extracted from Streptomyces Exfoliatus</article-title><source>FASEB J.</source><year>2019</year><volume>33</volume><fpage>637.4</fpage><pub-id pub-id-type="doi">10.1096/fasebj.2019.33.1_supplement.637.4</pub-id></element-citation></ref><ref id="B8-ijms-24-01114"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rangseekaew</surname><given-names>P.</given-names></name>
<name><surname>Pathom-Aree</surname><given-names>W.</given-names></name>
</person-group><article-title>Cave Actinobacteria as Producers of Bioactive Metabolites</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>387</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00387</pub-id><pub-id pub-id-type="pmid">30967844</pub-id></element-citation></ref><ref id="B9-ijms-24-01114"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Coppieters</surname><given-names>W.</given-names></name>
<name><surname>Karim</surname><given-names>L.</given-names></name>
<name><surname>Baurain</surname><given-names>D.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>Isolation, Characterization, and Antibacterial Activity of Hard-to-Culture Actinobacteria from Cave Moonmilk Deposits</article-title><source>Antibiotics</source><year>2018</year><volume>7</volume><elocation-id>E28</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics7020028</pub-id></element-citation></ref><ref id="B10-ijms-24-01114"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Ca&#x00142;usi&#x00144;ska</surname><given-names>M.</given-names></name>
<name><surname>Delfosse</surname><given-names>P.</given-names></name>
<name><surname>Carnol</surname><given-names>M.</given-names></name>
<name><surname>Barton</surname><given-names>H.A.</given-names></name>
<name><surname>Hayette</surname><given-names>M.-P.</given-names></name>
<name><surname>Smargiasso</surname><given-names>N.</given-names></name>
<etal/>
</person-group><article-title>A Phenotypic and Genotypic Analysis of the Antimicrobial Potential of Cultivable Streptomyces Isolated from Cave Moonmilk Deposits</article-title><source>Front. Microbiol.</source><year>2016</year><volume>7</volume><fpage>1455</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.01455</pub-id><pub-id pub-id-type="pmid">27708627</pub-id></element-citation></ref><ref id="B11-ijms-24-01114"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borsato</surname><given-names>A.</given-names></name>
<name><surname>Frisia</surname><given-names>S.</given-names></name>
<name><surname>Jones</surname><given-names>B.</given-names></name>
<name><surname>Van Der Borg</surname><given-names>K.</given-names></name>
</person-group><article-title>Calcite Moonmilk: Crystal Morphology and Environment of Formation in Caves in the Italian Alps</article-title><source>J. Sediment. Res.</source><year>2000</year><volume>70</volume><fpage>1171</fpage><lpage>1182</lpage><pub-id pub-id-type="doi">10.1306/032300701171</pub-id></element-citation></ref><ref id="B12-ijms-24-01114"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ca&#x000f1;averas</surname><given-names>J.C.</given-names></name>
<name><surname>Cuezva</surname><given-names>S.</given-names></name>
<name><surname>Sanchez-Moral</surname><given-names>S.</given-names></name>
<name><surname>Lario</surname><given-names>J.</given-names></name>
<name><surname>Laiz</surname><given-names>L.</given-names></name>
<name><surname>Gonzalez</surname><given-names>J.M.</given-names></name>
<name><surname>Saiz-Jimenez</surname><given-names>C.</given-names></name>
</person-group><article-title>On the Origin of Fiber Calcite Crystals in Moonmilk Deposits</article-title><source>Naturwissenschaften</source><year>2006</year><volume>93</volume><fpage>27</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1007/s00114-005-0052-3</pub-id><pub-id pub-id-type="pmid">16240102</pub-id></element-citation></ref><ref id="B13-ijms-24-01114"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reinbacher</surname><given-names>W.R.</given-names></name>
</person-group><article-title>Is It Gnome, Is It Berg, Is It Mont, It It Mond? An Updated View of the Origin and Etymology of Moonmilk</article-title><source>Bull. Natl. Speleol. Soc.</source><year>1994</year><volume>56</volume><fpage>1</fpage><lpage>13</lpage></element-citation></ref><ref id="B14-ijms-24-01114"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Miller</surname><given-names>A.Z.</given-names></name>
<name><surname>Dion&#x000ed;sio</surname><given-names>A.</given-names></name>
<name><surname>Jurado</surname><given-names>V.</given-names></name>
<name><surname>Cuezva</surname><given-names>S.</given-names></name>
<name><surname>Sanchez-Moral</surname><given-names>S.</given-names></name>
<name><surname>Ca&#x000f1;averas</surname><given-names>J.C.</given-names></name>
<name><surname>Saiz-Jimenez</surname><given-names>C.</given-names></name>
</person-group><article-title>Biomineralization by cave dwelling microorganisms</article-title><source>Advances in Geochemistry Research</source><person-group person-group-type="editor">
<name><surname>Sanjurjo Sanch&#x000e9;z</surname><given-names>J.</given-names></name>
</person-group><publisher-name>Nova Science Publishers</publisher-name><publisher-loc>Hauppauge, NY, USA</publisher-loc><year>2013</year><volume>Volume 5</volume><fpage>77</fpage><lpage>105</lpage></element-citation></ref><ref id="B15-ijms-24-01114"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Tenconi</surname><given-names>E.</given-names></name>
<name><surname>Ca&#x00142;usi&#x00144;ska</surname><given-names>M.</given-names></name>
<name><surname>Delfosse</surname><given-names>P.</given-names></name>
<name><surname>Hanikenne</surname><given-names>M.</given-names></name>
<name><surname>Baurain</surname><given-names>D.</given-names></name>
<name><surname>Comp&#x000e8;re</surname><given-names>P.</given-names></name>
<etal/>
</person-group><article-title>Assessment of the Potential Role of Streptomyces in Cave Moonmilk Formation</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><fpage>1181</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2017.01181</pub-id><pub-id pub-id-type="pmid">28706508</pub-id></element-citation></ref><ref id="B16-ijms-24-01114"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cirigliano</surname><given-names>A.</given-names></name>
<name><surname>Tomassetti</surname><given-names>M.C.</given-names></name>
<name><surname>Di Pietro</surname><given-names>M.</given-names></name>
<name><surname>Mura</surname><given-names>F.</given-names></name>
<name><surname>Maneschi</surname><given-names>M.L.</given-names></name>
<name><surname>Gentili</surname><given-names>M.D.</given-names></name>
<name><surname>Cardazzo</surname><given-names>B.</given-names></name>
<name><surname>Arrighi</surname><given-names>C.</given-names></name>
<name><surname>Mazzoni</surname><given-names>C.</given-names></name>
<name><surname>Negri</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>Calcite Moonmilk of Microbial Origin in the Etruscan Tomba Degli Scudi in Tarquinia, Italy</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>15839</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-34134-y</pub-id><?supplied-pmid 30367083?><pub-id pub-id-type="pmid">30367083</pub-id></element-citation></ref><ref id="B17-ijms-24-01114"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seifan</surname><given-names>M.</given-names></name>
<name><surname>Berenjian</surname><given-names>A.</given-names></name>
</person-group><article-title>Microbially Induced Calcium Carbonate Precipitation: A Widespread Phenomenon in the Biological World</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>4693</fpage><lpage>4708</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09861-5</pub-id><?supplied-pmid 31076835?><pub-id pub-id-type="pmid">31076835</pub-id></element-citation></ref><ref id="B18-ijms-24-01114"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Portillo</surname><given-names>M.C.</given-names></name>
<name><surname>Gonzalez</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Moonmilk Deposits Originate from Specific Bacterial Communities in Altamira Cave (Spain)</article-title><source>Microb. Ecol.</source><year>2011</year><volume>61</volume><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1007/s00248-010-9731-5</pub-id><pub-id pub-id-type="pmid">20717660</pub-id></element-citation></ref><ref id="B19-ijms-24-01114"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sp&#x000f6;tl</surname><given-names>C.</given-names></name>
</person-group><article-title>Moonmilk as a Human and Veterinary Medicine: Evidence of Past Artisan Mining in Caves of the Austrian Alps</article-title><source>Int. J. Speleol.</source><year>2018</year><volume>47</volume><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.5038/1827-806X.47.2.2174</pub-id></element-citation></ref><ref id="B20-ijms-24-01114"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Pessi</surname><given-names>I.S.</given-names></name>
<name><surname>Arguelles-Arias</surname><given-names>A.</given-names></name>
<name><surname>Noirfalise</surname><given-names>P.</given-names></name>
<name><surname>Luis</surname><given-names>G.</given-names></name>
<name><surname>Ongena</surname><given-names>M.</given-names></name>
<name><surname>Barton</surname><given-names>H.</given-names></name>
<name><surname>Carnol</surname><given-names>M.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>Streptomyces Lunaelactis Sp. Nov., a Novel Ferroverdin A-Producing Streptomyces Species Isolated from a Moonmilk Speleothem</article-title><source>Antonie Van Leeuwenhoek</source><year>2015</year><volume>107</volume><fpage>519</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1007/s10482-014-0348-4</pub-id><pub-id pub-id-type="pmid">25491121</pub-id></element-citation></ref><ref id="B21-ijms-24-01114"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Calusinska</surname><given-names>M.</given-names></name>
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Anderssen</surname><given-names>S.</given-names></name>
<name><surname>Adam</surname><given-names>D.</given-names></name>
<name><surname>Tenconi</surname><given-names>E.</given-names></name>
<name><surname>Deflandre</surname><given-names>B.</given-names></name>
<name><surname>Coppieters</surname><given-names>W.</given-names></name>
<name><surname>Karim</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Complete Genome Sequence of Streptomyces Lunaelactis MM109T, Isolated from Cave Moonmilk Deposits</article-title><source>Genome. Announc.</source><year>2018</year><volume>6</volume><fpage>e00435-18</fpage><pub-id pub-id-type="doi">10.1128/genomeA.00435-18</pub-id><pub-id pub-id-type="pmid">29798921</pub-id></element-citation></ref><ref id="B22-ijms-24-01114"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Baiwir</surname><given-names>D.</given-names></name>
<name><surname>De Pauw</surname><given-names>E.</given-names></name>
<name><surname>Mazzucchelli</surname><given-names>G.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>On the Risks of Phylogeny-Based Strain Prioritization for Drug Discovery: Streptomyces Lunaelactis as a Case Study</article-title><source>Biomolecules</source><year>2020</year><volume>10</volume><elocation-id>E1027</elocation-id><pub-id pub-id-type="doi">10.3390/biom10071027</pub-id><?supplied-pmid 32664387?><pub-id pub-id-type="pmid">32664387</pub-id></element-citation></ref><ref id="B23-ijms-24-01114"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Baiwir</surname><given-names>D.</given-names></name>
<name><surname>Mazzucchelli</surname><given-names>G.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>Structure of New Ferroverdins Recruiting Unconventional Ferrous Iron Chelating Agents</article-title><source>Biomolecules</source><year>2022</year><volume>12</volume><elocation-id>752</elocation-id><pub-id pub-id-type="doi">10.3390/biom12060752</pub-id><?supplied-pmid 35740878?><pub-id pub-id-type="pmid">35740878</pub-id></element-citation></ref><ref id="B24-ijms-24-01114"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinet</surname><given-names>L.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>Deflandre</surname><given-names>B.</given-names></name>
<name><surname>Maciejewska</surname><given-names>M.</given-names></name>
<name><surname>Tellatin</surname><given-names>D.</given-names></name>
<name><surname>Tenconi</surname><given-names>E.</given-names></name>
<name><surname>Smargiasso</surname><given-names>N.</given-names></name>
<name><surname>de Pauw</surname><given-names>E.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators</article-title><source>mBio</source><year>2019</year><volume>10</volume><fpage>e01230-19</fpage><pub-id pub-id-type="doi">10.1128/mBio.01230-19</pub-id><pub-id pub-id-type="pmid">31409675</pub-id></element-citation></ref><ref id="B25-ijms-24-01114"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Huang</surname><given-names>H.</given-names></name>
<name><surname>Luo</surname><given-names>M.</given-names></name>
<name><surname>Zuo</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>B.</given-names></name>
<name><surname>Sun</surname><given-names>A.</given-names></name>
<name><surname>Cheng</surname><given-names>Y.-Q.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
</person-group><article-title>Biosynthesis of Himastatin: Assembly Line and Characterization of Three Cytochrome P450 Enzymes Involved in the Post-Tailoring Oxidative Steps</article-title><source>Angew. Chem. Int. Ed. Engl.</source><year>2011</year><volume>50</volume><fpage>7797</fpage><lpage>7802</lpage><pub-id pub-id-type="doi">10.1002/anie.201102305</pub-id><?supplied-pmid 21726028?><pub-id pub-id-type="pmid">21726028</pub-id></element-citation></ref><ref id="B26-ijms-24-01114"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xie</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<name><surname>Qin</surname><given-names>X.</given-names></name>
<name><surname>Ju</surname><given-names>J.</given-names></name>
<name><surname>Ma</surname><given-names>J.</given-names></name>
</person-group><article-title>Enhancement of Himastatin Bioproduction via Inactivation of Atypical Repressors in Streptomyces Hygroscopicus</article-title><source>Metab. Eng. Commun.</source><year>2019</year><volume>8</volume><fpage>e00084</fpage><pub-id pub-id-type="doi">10.1016/j.mec.2018.e00084</pub-id><?supplied-pmid 30671346?><pub-id pub-id-type="pmid">30671346</pub-id></element-citation></ref><ref id="B27-ijms-24-01114"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kautsar</surname><given-names>S.A.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>J.C.</given-names></name>
<name><surname>Terlouw</surname><given-names>B.R.</given-names></name>
<name><surname>van der Hooft</surname><given-names>J.J.J.</given-names></name>
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Tracanna</surname><given-names>V.</given-names></name>
<name><surname>Suarez Duran</surname><given-names>H.G.</given-names></name>
<name><surname>Pascal Andreu</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>MIBiG 2.0: A Repository for Biosynthetic Gene Clusters of Known Function</article-title><source>Nucleic Acids Res.</source><year>2020</year><volume>48</volume><fpage>D454</fpage><lpage>D458</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz882</pub-id><?supplied-pmid 31612915?><pub-id pub-id-type="pmid">31612915</pub-id></element-citation></ref><ref id="B28-ijms-24-01114"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fujimori</surname><given-names>D.G.</given-names></name>
<name><surname>Hrvatin</surname><given-names>S.</given-names></name>
<name><surname>Neumann</surname><given-names>C.S.</given-names></name>
<name><surname>Strieker</surname><given-names>M.</given-names></name>
<name><surname>Marahiel</surname><given-names>M.A.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Cloning and Characterization of the Biosynthetic Gene Cluster for Kutznerides</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2007</year><volume>104</volume><fpage>16498</fpage><lpage>16503</lpage><pub-id pub-id-type="doi">10.1073/pnas.0708242104</pub-id><pub-id pub-id-type="pmid">17940045</pub-id></element-citation></ref><ref id="B29-ijms-24-01114"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W.-T.</given-names></name>
<name><surname>Lamsa</surname><given-names>A.</given-names></name>
<name><surname>Wong</surname><given-names>W.R.</given-names></name>
<name><surname>Boudreau</surname><given-names>P.D.</given-names></name>
<name><surname>Kersten</surname><given-names>R.</given-names></name>
<name><surname>Peng</surname><given-names>Y.</given-names></name>
<name><surname>Moree</surname><given-names>W.J.</given-names></name>
<name><surname>Duggan</surname><given-names>B.M.</given-names></name>
<name><surname>Moore</surname><given-names>B.S.</given-names></name>
<name><surname>Gerwick</surname><given-names>W.H.</given-names></name>
<etal/>
</person-group><article-title>MS/MS-Based Networking and Peptidogenomics Guided Genome Mining Revealed the Stenothricin Gene Cluster in Streptomyces Roseosporus</article-title><source>J. Antibiot.</source><year>2014</year><volume>67</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1038/ja.2013.99</pub-id></element-citation></ref><ref id="B30-ijms-24-01114"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>H.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Wan</surname><given-names>D.</given-names></name>
<name><surname>Qi</surname><given-names>J.</given-names></name>
<name><surname>Gong</surname><given-names>R.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
</person-group><article-title>Characterization of the Aurantimycin Biosynthetic Gene Cluster and Enhancing Its Production by Manipulating Two Pathway-Specific Activators in Streptomyces Aurantiacus JA 4570</article-title><source>Microb. Cell Factories</source><year>2016</year><volume>15</volume><fpage>160</fpage><pub-id pub-id-type="doi">10.1186/s12934-016-0559-7</pub-id></element-citation></ref><ref id="B31-ijms-24-01114"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Broberg</surname><given-names>A.</given-names></name>
<name><surname>Menkis</surname><given-names>A.</given-names></name>
<name><surname>Vasiliauskas</surname><given-names>R.</given-names></name>
</person-group><article-title>Kutznerides 1&#x02212;4, Depsipeptides from the Actinomycete Kutzneria Sp. 744 Inhabiting Mycorrhizal Roots of Picea Abies Seedlings</article-title><source>J. Nat. Prod.</source><year>2006</year><volume>69</volume><fpage>97</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1021/np050378g</pub-id><pub-id pub-id-type="pmid">16441076</pub-id></element-citation></ref><ref id="B32-ijms-24-01114"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gr&#x000e4;fe</surname><given-names>U.</given-names></name>
<name><surname>Schlegel</surname><given-names>R.</given-names></name>
<name><surname>Ritzau</surname><given-names>M.</given-names></name>
<name><surname>Ihn</surname><given-names>W.</given-names></name>
<name><surname>Dornberger</surname><given-names>K.</given-names></name>
<name><surname>Stengel</surname><given-names>C.</given-names></name>
<name><surname>Fleck</surname><given-names>W.F.</given-names></name>
<name><surname>Gutsche</surname><given-names>W.</given-names></name>
<name><surname>H&#x000e4;rtl</surname><given-names>A.</given-names></name>
<name><surname>Paulus</surname><given-names>E.F.</given-names></name>
</person-group><article-title>Aurantimycins, New Depsipeptide Antibiotics from Streptomyces Aumntiacus IMET 43917 Production, Isolation, Structure Elucidation, and Biological Activity</article-title><source>J. Antibiot.</source><year>1995</year><volume>48</volume><fpage>119</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.48.119</pub-id></element-citation></ref><ref id="B33-ijms-24-01114"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Leet</surname><given-names>J.E.</given-names></name>
<name><surname>Schroeder</surname><given-names>D.R.</given-names></name>
<name><surname>Golik</surname><given-names>J.</given-names></name>
<name><surname>Matson</surname><given-names>J.A.</given-names></name>
<name><surname>Doyle</surname><given-names>T.W.</given-names></name>
<name><surname>Lam</surname><given-names>K.S.</given-names></name>
<name><surname>Hill</surname><given-names>S.E.</given-names></name>
<name><surname>Lee</surname><given-names>M.S.</given-names></name>
<name><surname>Whitney</surname><given-names>J.L.</given-names></name>
<name><surname>Krishnan</surname><given-names>B.S.</given-names></name>
</person-group><article-title>Himastatin, a New Antitumor Antibiotic from Streptomyces Hygroscopicus. III. Structural Elucidation</article-title><source>J. Antibiot.</source><year>1996</year><volume>49</volume><fpage>299</fpage><lpage>311</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.49.299</pub-id></element-citation></ref><ref id="B34-ijms-24-01114"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hasenb&#x000f6;hler</surname><given-names>A.</given-names></name>
<name><surname>Kneifel</surname><given-names>H.</given-names></name>
<name><surname>K&#x000f6;nig</surname><given-names>W.A.</given-names></name>
<name><surname>Z&#x000e4;hner</surname><given-names>H.</given-names></name>
<name><surname>Zeiler</surname><given-names>H.J.</given-names></name>
</person-group><article-title>[Metabolic products of microorganisms. 134. Stenothricin, a new inhibitor of the bacterial cell wall synthesis (author&#x02019;s transl)]</article-title><source>Arch. Microbiol.</source><year>1974</year><volume>99</volume><fpage>307</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1007/BF00696245</pub-id><?supplied-pmid 4215397?><pub-id pub-id-type="pmid">4215397</pub-id></element-citation></ref><ref id="B35-ijms-24-01114"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Neumann</surname><given-names>C.S.</given-names></name>
<name><surname>Jiang</surname><given-names>W.</given-names></name>
<name><surname>Heemstra</surname><given-names>J.R.</given-names><suffix>Jr.</suffix></name>
<name><surname>Gontang</surname><given-names>E.A.</given-names></name>
<name><surname>Kolter</surname><given-names>R.</given-names></name>
<name><surname>Walsh</surname><given-names>C.T.</given-names></name>
</person-group><article-title>Biosynthesis of Piperazic Acid via N5-Hydroxy-Ornithine in Kutzneria Spp. 744</article-title><source>ChemBioChem</source><year>2012</year><volume>13</volume><fpage>972</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1002/cbic.201200054</pub-id><pub-id pub-id-type="pmid">22522643</pub-id></element-citation></ref><ref id="B36-ijms-24-01114"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Du</surname><given-names>Y.-L.</given-names></name>
<name><surname>He</surname><given-names>H.-Y.</given-names></name>
<name><surname>Higgins</surname><given-names>M.A.</given-names></name>
<name><surname>Ryan</surname><given-names>K.S.</given-names></name>
</person-group><article-title>A Heme-Dependent Enzyme Forms the Nitrogen&#x02013;Nitrogen Bond in Piperazate</article-title><source>Nat. Chem. Biol.</source><year>2017</year><volume>13</volume><fpage>836</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2411</pub-id><pub-id pub-id-type="pmid">28628093</pub-id></element-citation></ref><ref id="B37-ijms-24-01114"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morgan</surname><given-names>K.D.</given-names></name>
<name><surname>Andersen</surname><given-names>R.J.</given-names></name>
<name><surname>Ryan</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Piperazic Acid-Containing Natural Products: Structures and Biosynthesis</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>1628</fpage><lpage>1653</lpage><pub-id pub-id-type="doi">10.1039/C8NP00076J</pub-id><?supplied-pmid 30949650?><pub-id pub-id-type="pmid">30949650</pub-id></element-citation></ref><ref id="B38-ijms-24-01114"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>Z.-W.</given-names></name>
<name><surname>Niikura</surname><given-names>H.</given-names></name>
<name><surname>Morgan</surname><given-names>K.D.</given-names></name>
<name><surname>Vacariu</surname><given-names>C.M.</given-names></name>
<name><surname>Andersen</surname><given-names>R.J.</given-names></name>
<name><surname>Ryan</surname><given-names>K.S.</given-names></name>
</person-group><article-title>Free Piperazic Acid as a Precursor to Nonribosomal Peptides</article-title><source>J. Am. Chem. Soc.</source><year>2022</year><volume>144</volume><fpage>13556</fpage><lpage>13564</lpage><pub-id pub-id-type="doi">10.1021/jacs.2c03660</pub-id><?supplied-pmid 35867963?><pub-id pub-id-type="pmid">35867963</pub-id></element-citation></ref><ref id="B39-ijms-24-01114"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chevrette</surname><given-names>M.G.</given-names></name>
<name><surname>Aicheler</surname><given-names>F.</given-names></name>
<name><surname>Kohlbacher</surname><given-names>O.</given-names></name>
<name><surname>Currie</surname><given-names>C.R.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
</person-group><article-title>SANDPUMA: Ensemble Predictions of Nonribosomal Peptide Chemistry Reveal Biosynthetic Diversity across Actinobacteria</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>3202</fpage><lpage>3210</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btx400</pub-id><?supplied-pmid 28633438?><pub-id pub-id-type="pmid">28633438</pub-id></element-citation></ref><ref id="B40-ijms-24-01114"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Du</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Huang</surname><given-names>T.</given-names></name>
<name><surname>Tao</surname><given-names>M.</given-names></name>
<name><surname>Deng</surname><given-names>Z.</given-names></name>
<name><surname>Lin</surname><given-names>S.</given-names></name>
</person-group><article-title>Identification and Characterization of the Biosynthetic Gene Cluster of Polyoxypeptin A, a Potent Apoptosis Inducer</article-title><source>BMC Microbiol.</source><year>2014</year><volume>14</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-14-30</pub-id><pub-id pub-id-type="pmid">24506891</pub-id></element-citation></ref><ref id="B41-ijms-24-01114"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pohlmann</surname><given-names>V.</given-names></name>
<name><surname>Marahiel</surname><given-names>M.A.</given-names></name>
</person-group><article-title>&#x003b4;-Amino Group Hydroxylation of L-Ornithine during Coelichelin Biosynthesis</article-title><source>Org. Biomol. Chem.</source><year>2008</year><volume>6</volume><fpage>1843</fpage><lpage>1848</lpage><pub-id pub-id-type="doi">10.1039/b801016a</pub-id><pub-id pub-id-type="pmid">18452021</pub-id></element-citation></ref><ref id="B42-ijms-24-01114"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>H.</given-names></name>
<name><surname>Lin</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>D.</given-names></name>
<name><surname>Gu</surname><given-names>Q.</given-names></name>
<name><surname>Zhu</surname><given-names>T.</given-names></name>
</person-group><article-title>[OSMAC (one strain many compounds) approach in the research of microbial metabolites&#x02014;A review]</article-title><source>Wei Sheng Wu Xue Bao</source><year>2010</year><volume>50</volume><fpage>701</fpage><lpage>709</lpage><pub-id pub-id-type="pmid">20687332</pub-id></element-citation></ref><ref id="B43-ijms-24-01114"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rigali</surname><given-names>S.</given-names></name>
<name><surname>Anderssen</surname><given-names>S.</given-names></name>
<name><surname>Na&#x000f4;m&#x000e9;</surname><given-names>A.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Cracking the Regulatory Code of Biosynthetic Gene Clusters as a Strategy for Natural Product Discovery</article-title><source>Biochem. Pharmacol.</source><year>2018</year><volume>153</volume><fpage>24</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2018.01.007</pub-id><?supplied-pmid 29309762?><pub-id pub-id-type="pmid">29309762</pub-id></element-citation></ref><ref id="B44-ijms-24-01114"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rigali</surname><given-names>S.</given-names></name>
<name><surname>Titgemeyer</surname><given-names>F.</given-names></name>
<name><surname>Barends</surname><given-names>S.</given-names></name>
<name><surname>Mulder</surname><given-names>S.</given-names></name>
<name><surname>Thomae</surname><given-names>A.W.</given-names></name>
<name><surname>Hopwood</surname><given-names>D.A.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Feast or Famine: The Global Regulator DasR Links Nutrient Stress to Antibiotic Production by Streptomyces</article-title><source>EMBO Rep.</source><year>2008</year><volume>9</volume><fpage>670</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1038/embor.2008.83</pub-id><?supplied-pmid 18511939?><pub-id pub-id-type="pmid">18511939</pub-id></element-citation></ref><ref id="B45-ijms-24-01114"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015a;wi&#x00105;tek</surname><given-names>M.A.</given-names></name>
<name><surname>Urem</surname><given-names>M.</given-names></name>
<name><surname>Tenconi</surname><given-names>E.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Engineering of N-Acetylglucosamine Metabolism for Improved Antibiotic Production in Streptomyces Coelicolor A3(2) and an Unsuspected Role of NagA in Glucosamine Metabolism</article-title><source>Bioengineered</source><year>2012</year><volume>3</volume><fpage>280</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.4161/bioe.21371</pub-id><?supplied-pmid 22892576?><pub-id pub-id-type="pmid">22892576</pub-id></element-citation></ref><ref id="B46-ijms-24-01114"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shimada</surname><given-names>N.</given-names></name>
<name><surname>Morimoto</surname><given-names>K.</given-names></name>
<name><surname>Naganawa</surname><given-names>H.</given-names></name>
<name><surname>Takita</surname><given-names>T.</given-names></name>
<name><surname>Hamada</surname><given-names>M.</given-names></name>
<name><surname>Maeda</surname><given-names>K.</given-names></name>
<name><surname>Takeuchi</surname><given-names>T.</given-names></name>
<name><surname>Umezawa</surname><given-names>H.</given-names></name>
</person-group><article-title>ANTRIMYCIN, A NEW PEPTIDE ANTIBIOTIC</article-title><source>J. Antibiot. (Tokyo)</source><year>1981</year><volume>34</volume><fpage>1613</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.7164/antibiotics.34.1613</pub-id><pub-id pub-id-type="pmid">7333974</pub-id></element-citation></ref><ref id="B47-ijms-24-01114"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>P.</given-names></name>
<name><surname>Ren</surname><given-names>B.</given-names></name>
<name><surname>Song</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>G.</given-names></name>
<name><surname>He</surname><given-names>W.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Oyeleye</surname><given-names>A.</given-names></name>
<name><surname>Dai</surname><given-names>H.</given-names></name>
<name><surname>Zhang</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Antibacterial Polyene-Polyol Macrolides and Cyclic Peptides from the Marine-Derived Streptomyces Sp. MS110128</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2021</year><volume>105</volume><fpage>4975</fpage><lpage>4986</lpage><pub-id pub-id-type="doi">10.1007/s00253-021-11226-w</pub-id><pub-id pub-id-type="pmid">34146138</pub-id></element-citation></ref><ref id="B48-ijms-24-01114"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moumbock</surname><given-names>A.F.A.</given-names></name>
<name><surname>Gao</surname><given-names>M.</given-names></name>
<name><surname>Qaseem</surname><given-names>A.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Kirchner</surname><given-names>P.A.</given-names></name>
<name><surname>Ndingkokhar</surname><given-names>B.</given-names></name>
<name><surname>Bekono</surname><given-names>B.D.</given-names></name>
<name><surname>Simoben</surname><given-names>C.V.</given-names></name>
<name><surname>Babiaka</surname><given-names>S.B.</given-names></name>
<name><surname>Malange</surname><given-names>Y.I.</given-names></name>
<etal/>
</person-group><article-title>StreptomeDB 3.0: An Updated Compendium of Streptomycetes Natural Products</article-title><source>Nucleic. Acids Res.</source><year>2021</year><volume>49</volume><fpage>D600</fpage><lpage>D604</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa868</pub-id><pub-id pub-id-type="pmid">33051671</pub-id></element-citation></ref><ref id="B49-ijms-24-01114"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Santen</surname><given-names>J.A.</given-names></name>
<name><surname>Poynton</surname><given-names>E.F.</given-names></name>
<name><surname>Iskakova</surname><given-names>D.</given-names></name>
<name><surname>McMann</surname><given-names>E.</given-names></name>
<name><surname>Alsup</surname><given-names>T.A.</given-names></name>
<name><surname>Clark</surname><given-names>T.N.</given-names></name>
<name><surname>Fergusson</surname><given-names>C.H.</given-names></name>
<name><surname>Fewer</surname><given-names>D.P.</given-names></name>
<name><surname>Hughes</surname><given-names>A.H.</given-names></name>
<name><surname>McCadden</surname><given-names>C.A.</given-names></name>
<etal/>
</person-group><article-title>The Natural Products Atlas 2.0: A Database of Microbially-Derived Natural Products</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1317</fpage><lpage>D1323</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab941</pub-id><pub-id pub-id-type="pmid">34718710</pub-id></element-citation></ref><ref id="B50-ijms-24-01114"><label>50.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<name><surname>Peoples</surname><given-names>A.S.</given-names></name>
<name><surname>Ling</surname><given-names>L.L.</given-names></name>
<name><surname>Lewis</surname><given-names>K.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
</person-group><article-title>Novel Antibiotics Patent US-2011136752-A1 PubChem</article-title><comment>Available online: <ext-link xlink:href="https://pubchem.ncbi.nlm.nih.gov/patent/US-2011136752-A1" ext-link-type="uri">https://pubchem.ncbi.nlm.nih.gov/patent/US-2011136752-A1</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-10-31">(accessed on 31 October 2022)</date-in-citation></element-citation></ref><ref id="B51-ijms-24-01114"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tenconi</surname><given-names>E.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
</person-group><article-title>Self-Resistance Mechanisms to DNA-Damaging Antitumor Antibiotics in Actinobacteria</article-title><source>Curr. Opin. Microbiol.</source><year>2018</year><volume>45</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2018.03.003</pub-id><pub-id pub-id-type="pmid">29642052</pub-id></element-citation></ref><ref id="B52-ijms-24-01114"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Besier</surname><given-names>S.</given-names></name>
<name><surname>Ludwig</surname><given-names>A.</given-names></name>
<name><surname>Zander</surname><given-names>J.</given-names></name>
<name><surname>Brade</surname><given-names>V.</given-names></name>
<name><surname>Wichelhaus</surname><given-names>T.A.</given-names></name>
</person-group><article-title>Linezolid Resistance in Staphylococcus Aureus: Gene Dosage Effect, Stability, Fitness Costs, and Cross-Resistances</article-title><source>Antimicrob. Agents Chemother.</source><year>2008</year><volume>52</volume><fpage>1570</fpage><lpage>1572</lpage><pub-id pub-id-type="doi">10.1128/AAC.01098-07</pub-id><pub-id pub-id-type="pmid">18212098</pub-id></element-citation></ref><ref id="B53-ijms-24-01114"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tedim</surname><given-names>A.P.</given-names></name>
<name><surname>Lanza</surname><given-names>V.F.</given-names></name>
<name><surname>Rodr&#x000ed;guez</surname><given-names>C.M.</given-names></name>
<name><surname>Freitas</surname><given-names>A.R.</given-names></name>
<name><surname>Novais</surname><given-names>C.</given-names></name>
<name><surname>Peixe</surname><given-names>L.</given-names></name>
<name><surname>Baquero</surname><given-names>F.</given-names></name>
<name><surname>Coque</surname><given-names>T.M.</given-names></name>
</person-group><article-title>Fitness Cost of Vancomycin-Resistant Enterococcus Faecium Plasmids Associated with Hospital Infection Outbreaks</article-title><source>J. Antimicrob. Chemother.</source><year>2021</year><volume>76</volume><fpage>2757</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1093/jac/dkab249</pub-id><pub-id pub-id-type="pmid">34450635</pub-id></element-citation></ref><ref id="B54-ijms-24-01114"><label>54.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Kieser</surname><given-names>T.</given-names></name>
<name><surname>Bibb</surname><given-names>M.J.</given-names></name>
<name><surname>Buttner</surname><given-names>M.J.</given-names></name>
<name><surname>Chater</surname><given-names>K.F.</given-names></name>
<name><surname>Hopwood</surname><given-names>D.A.</given-names></name>
</person-group><source>Practical Streptomyces Genetics</source><publisher-name>John Innes Foundation</publisher-name><publisher-loc>Norwich, UK</publisher-loc><year>2000</year></element-citation></ref><ref id="B55-ijms-24-01114"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Shaw</surname><given-names>S.</given-names></name>
<name><surname>Kloosterman</surname><given-names>A.M.</given-names></name>
<name><surname>Charlop-Powers</surname><given-names>Z.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
</person-group><article-title>AntiSMASH 6.0: Improving Cluster Detection and Comparison Capabilities</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>W29</fpage><lpage>W35</lpage><pub-id pub-id-type="doi">10.1093/nar/gkab335</pub-id><?supplied-pmid 33978755?><pub-id pub-id-type="pmid">33978755</pub-id></element-citation></ref><ref id="B56-ijms-24-01114"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>R&#x000f6;ttig</surname><given-names>M.</given-names></name>
<name><surname>Medema</surname><given-names>M.H.</given-names></name>
<name><surname>Blin</surname><given-names>K.</given-names></name>
<name><surname>Weber</surname><given-names>T.</given-names></name>
<name><surname>Rausch</surname><given-names>C.</given-names></name>
<name><surname>Kohlbacher</surname><given-names>O.</given-names></name>
</person-group><article-title>NRPSpredictor2--a Web Server for Predicting NRPS Adenylation Domain Specificity</article-title><source>Nucleic Acids Res.</source><year>2011</year><volume>39</volume><fpage>W362</fpage><lpage>W367</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr323</pub-id><?supplied-pmid 21558170?><pub-id pub-id-type="pmid">21558170</pub-id></element-citation></ref><ref id="B57-ijms-24-01114"><label>57.</label><element-citation publication-type="gov"><person-group person-group-type="author">
<name><surname>Humphries</surname><given-names>R.M.</given-names></name>
<name><surname>Ambler</surname><given-names>J.</given-names></name>
<name><surname>Mitchell</surname><given-names>S.L.</given-names></name>
<name><surname>Castanheira</surname><given-names>M.</given-names></name>
<name><surname>Dingle</surname><given-names>T.</given-names></name>
<name><surname>Hindler</surname><given-names>J.A.</given-names></name>
<name><surname>Koeth</surname><given-names>L.</given-names></name>
<name><surname>Sei</surname><given-names>K.</given-names></name>
</person-group><article-title>CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests PMC</article-title><comment>Available online: <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869819/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869819/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2022-11-27">(accessed on 27 November 2022)</date-in-citation></element-citation></ref><ref id="B58-ijms-24-01114"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Dieases (ESCMID)</collab>
</person-group><article-title>EUCAST Definitive Document E.Def 1.2, May 2000: Terminology Relating to Methods for the Determination of Susceptibility of Bacteria to Antimicrobial Agents</article-title><source>Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis.</source><year>2000</year><volume>6</volume><fpage>503</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1046/j.1469-0691.2000.00149.x</pub-id></element-citation></ref><ref id="B59-ijms-24-01114"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gubbens</surname><given-names>J.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
<name><surname>Zhu</surname><given-names>H.</given-names></name>
<name><surname>Filippov</surname><given-names>D.V.</given-names></name>
<name><surname>Florea</surname><given-names>B.I.</given-names></name>
<name><surname>Rigali</surname><given-names>S.</given-names></name>
<name><surname>Overkleeft</surname><given-names>H.S.</given-names></name>
<name><surname>van Wezel</surname><given-names>G.P.</given-names></name>
</person-group><article-title>Intertwined Precursor Supply during Biosynthesis of the Catecholate-Hydroxamate Siderophores Qinichelins in Streptomyces Sp. MBT76</article-title><source>ACS Chem. Biol.</source><year>2017</year><volume>12</volume><fpage>2756</fpage><lpage>2766</lpage><pub-id pub-id-type="doi">10.1021/acschembio.7b00597</pub-id><?supplied-pmid 28945067?><pub-id pub-id-type="pmid">28945067</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="ijms-24-01114-f001"><label>Figure 1</label><caption><p>Predicted biosynthetic pathways and substrate specificity of BGC 28a (<italic toggle="yes">lun</italic> cluster). Top: genes/proteins predicted to be involved in the Ornithine (Orn) and Piperazic acid (Piz) biosynthesis. Bottom: modules, domains, predicted amino acid building-blocks, and modifying reactions of NRPSs of BGC 28a predicted to generate a cyclized hexapeptide with a monoisotopic mass of 708.4041 Da. Abbreviations: A, adenylation domain; C, condensation domain; T, thiolation domain; TE, thioesterase domain; Ile, isoleucine; Phe, phenylalanine; Piz, piperazic acid.</p></caption><graphic xlink:href="ijms-24-01114-g001" position="float"/></fig><fig position="float" id="ijms-24-01114-f002"><label>Figure 2</label><caption><p>(<bold>a</bold>) Genome mining of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains where the 42 predicted BGCs are grouped in &#x02018;grapes&#x02019; of nodes where each node represents a BGC in one strain (from [<xref rid="B22-ijms-24-01114" ref-type="bibr">22</xref>]). Note the two grapes corresponding to BGC 28a and to BGC 28b found in strains either containing the linear plasmid pSLUN1a or pSLUN1b, respectively. (<bold>b</bold>) Heatmap of the metabolomic analysis of 11 <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains grown on ISP7 media. The zoom on the heatmap highlights the differential production patterns for metabolites with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> comprised between 700 and 800 Da and only present in the extract of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains that possess BGC 28a (MM109<sup>T</sup> and MM37). (<bold>c</bold>) Extracted ion chromatograms (EIC, from <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> 700 to 800) of the full extract of the 11 strains with a focus on the retention times of signals associated with compounds only detected in <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains with BGC 28a (MM109<sup>T</sup> and MM37). (<bold>d</bold>) HRMS-predicted molecular formula of compound <bold>1</bold> (for both the proton and the sodium adducts) associated with the main signal detected in EICs of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains MM37 and MM109<sup>T</sup>.</p></caption><graphic xlink:href="ijms-24-01114-g002" position="float"/></fig><fig position="float" id="ijms-24-01114-f003"><label>Figure 3</label><caption><p>HRMS/MS-based identification of the amino acid building-blocks of compound <bold>1</bold>. (<bold>a</bold>) NRPS genes of BGC 28a (<italic toggle="yes">lun</italic> cluster) and the predicted amino acid building-block sequence. (<bold>b</bold>) MS fragmentation spectrum and proposed structure of compound <bold>1</bold> (lunaemycin A). Only fragments corresponding to amino-acid or peptide <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> of the predicted peptide sequence are highlighted. Color code: orange, piperazic acid (Piz); grey, phenylalanine (Phe); blue, hydroxylated isoleucine (HO-Ile).</p></caption><graphic xlink:href="ijms-24-01114-g003" position="float"/></fig><fig position="float" id="ijms-24-01114-f004"><label>Figure 4</label><caption><p>HRMS/MS-based identification of fragmentation patterns of compound <bold>1</bold>. (<bold>a</bold>) MS fragmentation spectrum. (<bold>b</bold>) Structure of ions containing one to four Piz residues (these ions are highlighted by numbers in blue in the MS fragmentation spectrum). (<bold>c</bold>) Structure of fragment ions containing the phenylalanine building block (these ions are highlighted by numbers in green in the MS fragmentation spectrum. (<bold>d</bold>) Structure of fragment ions that contain a hydroxyl-isoleucine residue (these ions are highlighted by numbers in red in the MS fragmentation spectrum). (<bold>e</bold>) Structure of fragment ions seemingly resulting from the neutral loss of H<sub>2</sub>O further supporting the presence of hydroxylated isoleucine (these ions are highlighted by numbers in orange in the MS fragmentation spectrum).</p></caption><graphic xlink:href="ijms-24-01114-g004" position="float"/></fig><fig position="float" id="ijms-24-01114-f005"><label>Figure 5</label><caption><p>Structure elucidation of compounds <bold>1</bold> and <bold>2</bold> by NMR. (<bold>a</bold>) Compound <bold>1</bold>. (<bold>b</bold>) Compound <bold>2</bold>. (<bold>c</bold>) COSY and HMBC correlations that allowed to unambiguously confirm the location of the hydroxylation on compound <bold>1</bold>. See <xref rid="app1-ijms-24-01114" ref-type="app">supplementary Figures S2&#x02013;S6</xref>.</p></caption><graphic xlink:href="ijms-24-01114-g005" position="float"/></fig><fig position="float" id="ijms-24-01114-f006"><label>Figure 6</label><caption><p>GNPS of metabolites extracted from <italic toggle="yes">S. lunaelactis</italic> strains. Left panel: Constellations of compounds constructed based on GNPS processing the UPLC-MS/MS data obtained from the full extract of the eleven <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> strains grown on ISP7 medium. Each node in a constellation represents a parent mass (MS1) of a compound detected in one or more of the eleven full extracts analyzed. Right panel: Constellation of lunaemycins where nodes are linked by a straight line when they share similar fragmentation patterns. Pink and blue nodes: lunaemycins with solved and unsolved structure, respectively (see details in <xref rid="ijms-24-01114-t003" ref-type="table">Table 3</xref>, <xref rid="ijms-24-01114-f007" ref-type="fig">Figure 7</xref>, and <xref rid="app1-ijms-24-01114" ref-type="app">Supplementary Figures S7&#x02013;S20</xref>).</p></caption><graphic xlink:href="ijms-24-01114-g006" position="float"/></fig><fig position="float" id="ijms-24-01114-f007"><label>Figure 7</label><caption><p>UPLC-HRMS chromatograms and mass spectra of lunaemycins. Left panel: Extracted ion chromatogram (EIC) with <italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> signals ranging from 700 to 800 Da from the full extracts of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup> grown on ISP7 medium. Right panels: HRMS-predicted molecular formula of compound <bold>1</bold> to <bold>10c</bold> (for both the proton and the sodium adducts) associated with the main signal detected in the EIC displayed on the left panel.</p></caption><graphic xlink:href="ijms-24-01114-g007" position="float"/></fig><fig position="float" id="ijms-24-01114-f008"><label>Figure 8</label><caption><p>Agar-diffusion antibacterial activity assays of lunaemycins. 0.1 mg/mL of gentamicin was used as positive control, and a water/acetonitrile solution (1/9, <italic toggle="yes">v</italic>/<italic toggle="yes">v</italic>) was used as negative control.</p></caption><graphic xlink:href="ijms-24-01114-g008" position="float"/></fig><fig position="float" id="ijms-24-01114-f009"><label>Figure 9</label><caption><p>Proposed biosynthetic pathway of lunaemycin A. This model suggests that the Ile will be either N-hydroxylated before activation and recruitment by the A domain (like proposed for the coelichelin pathway) or hydroxylated once activated and tethered on the thiolation domain of Lun20 (like proposed for polyoxypeptin synthesis).</p></caption><graphic xlink:href="ijms-24-01114-g009" position="float"/></fig><table-wrap position="float" id="ijms-24-01114-t001"><object-id pub-id-type="pii">ijms-24-01114-t001_Table 1</object-id><label>Table 1</label><caption><p>Deduced functions of ORFs of the <italic toggle="yes">lun</italic> (BGC 28a) biosynthetic gene cluster of <italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">ORFs</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Closest Homologue in MiBIG Database (Protein ID)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Homology (Id/Cov)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Proposed Function</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Locus Tag Accession No.</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Name Size (aa)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38410 WP_108155188.1</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun1<break/>177</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">TmcL, hypothetical protein, &#x003b1;,&#x003b2;-epoxyketone BGC of <italic toggle="yes">Streptomyces chromofuscus</italic> (CUX96959.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">64/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38415 WP_108155189.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun2 <break/>278</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DUF4097 family beta strand repeat-containing protein, &#x003b1;,&#x003b2;-epoxyketone BGC of <italic toggle="yes">Streptomyces chromofuscus</italic> (CUX96960.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38420 WP_108155190.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun3 <break/>416</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Cytochrome P450, streptovaricin BGC of <italic toggle="yes">Streptomyces spectabilis</italic> (ASZ00144.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">61/97</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Product modification</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38425 WP_108155191.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun4 76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ferredoxin, caniferolide A BGC from <italic toggle="yes">Streptomyces caniferus</italic> (QBF51761.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52/82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Product modification</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38430 WP_254708284.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun5 <break/>179</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">GtrA family protein, monensin BGC from <italic toggle="yes">Streptomyces cinnamonensis</italic> (AAO65788.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">60/82</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38435 WP_159100457.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun6 <break/>746</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MPPL family transporter, alnumycin A BGC from <italic toggle="yes">Streptomyces</italic> sp. CM020 (ACI88887.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58/98</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Exporter</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38440 WP_108155192.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun7 <break/>409</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">MfnN, cytochrome P450, marformycin A BGC from <italic toggle="yes">Streptomyces drozdowiczii</italic> (AJV88386.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">37/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">product modification</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38445 WP_108155193.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun8 <break/>157</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hypothetical protein, no hit in MiBIG, closest to <italic toggle="yes">Streptomyces</italic> sp. Ag82_O1-15 (WP_095849664.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47/88</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38450 WP_108155194.1</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun9 <break/>531</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">MFS transporter, siamycin I BGC from <italic toggle="yes">Streptomyces</italic> sp. (BBD82029.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">72/93</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Resistance export</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38455 WP_108155195.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun10 <break/>241</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TetR/AcrR family transcriptional regulator, siamycin I BGC from <italic toggle="yes">Streptomyces</italic> sp. (BBD82030.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">61/96</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Resistance regulation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38460 WP_108155196.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun11 <break/>342</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">StenM, N-acetyl-gamma-glutamyl-phosphate reductase (ArgC), stenothricin BGC from <italic toggle="yes">Streptomyces roseosporus</italic> (EFE73305.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">81/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">L-ornithine synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38465 WP_108155197.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun12 <break/>417</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">StenJ, N(2)-acetyl-L-ornithine:2-oxoglutarate aminotransferase (ArgD), stenothricin BGC from <italic toggle="yes">Streptomyces roseosporus</italic> NRRL 15998 (EFE73302.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72/94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-ornithine synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38470 WP_108155198.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun13 <break/>300</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">StenK, N-acetylglutamate kinase (ArgB), stenothricin BGC from <italic toggle="yes">Streptomyces roseosporus</italic> (EFE73303.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">81/97</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">L-ornithine synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38475 WP_108155199.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun14 <break/>384</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">StenL, bifunctional N(2)-acetyl-L-ornithine:L-glutamate N-acetyltransferase (ArgJ), stenothricin BGC from <italic toggle="yes">Streptomyces roseosporus</italic> (EFE73304.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">L-ornithine synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38480 WP_108155200.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun15 <break/>70</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">KtzJ, aurantimycin A BGC from <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 (WP_016638464.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">71/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Building block modification</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38485 WP_108155201.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun16 <break/>444</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HmtM, lysine N(6)-hydroxylase/L-ornithine N(5)-oxygenase, himastatin BGC of <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42147.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63/97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Piz synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38490 WP_108155202.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun17 <break/>230</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">HmtC, piperazate synthase, himastatin BGC <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42137.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">69/95</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Piz synthesis</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38495 WP_108155203.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun18 <break/>235</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LmbU family transcriptional regulator, himastatin BGC <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42138.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69/95 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Regulation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38500 WP_108155204.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun19 <break/>100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">chorismate mutase, no hit in MiBIG, <italic toggle="yes">Streptomyces</italic> sp. SLBN-118 (WP_142214144.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">78/97 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Phe biosynthetic pathway</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38505 WP_108155205.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun20 <break/>1072</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OciC, non-ribosomal peptide synthetase (Module 3, domain C-A-T), cyanopeptolin BGC from <italic toggle="yes">Planktothrix agardhii</italic> NIVA-CYA 116 (ABI26079.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43/98 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incorporated aa: L-Ile</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38510 WP_108155206.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun21 <break/>400</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">NAD(P)/FAD-dependent oxidoreductase, aurantimycin A BGC from <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 (WP_016638468.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">53/99 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Hydroxylation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38515 WP_108155207.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun22 <break/>5462</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HmtL, non-ribosomal peptide synthetase (Modules 4/5/6/7, domains C-A-T-E/C-A-T/C-A-T-E/C-A-T-TE), himastatin BGC of <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42146.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55&#x02013;100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incorporated aa: D-Piz/L-Piz/D-Piz/L-Piz and peptide release and cyclization</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38520 WP_159100458.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun23 <break/>2167</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Non-ribosomal peptide synthetase (Module 1/2, domains A-T-E/C-A-T), aurantimycin A BGC from <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 (WP_016638470.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">53/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Incorporated aa: D-Phe/inactive</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38525 WP_108155209.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun24 <break/>259</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">KtzF thioesterase, alpha/beta fold hydrolase, himastatin BGC of <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42144.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">58/97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peptide release</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38530 WP_108155210.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun25 <break/>258</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">ABC transporter permease, aurantimycin A BGC from <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 (WP_016638474.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">51/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Drug resistance</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38535 WP_108155211.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun26 <break/>323</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daunorubicin resistance protein DrrA family ABC transporter ATP-binding protein, aurantimycin A BGC of <italic toggle="yes">Streptomyces aurantiacus</italic> JA 4570 (WP_016638473.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">66/94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drug resistance</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38540 WP_108155212.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun27 <break/>286</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">DUF4097 family beta strand repeat-containing protein, himastatin BGC <italic toggle="yes">Streptomyces himastatinicus</italic> (CBZ42150.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">39/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38545 WP_108155213.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun28 <break/>261</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3-oxoacyl-ACP reductase FabG, kiamycin biosynthetic gene cluster from <italic toggle="yes">Streptomyces</italic> sp. W007 (EHM27508.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">74/97</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38550 WP_108155214.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun29 <break/>285</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SARP family transcriptional regulator, mitomycin biosynthetic gene cluster from <italic toggle="yes">Streptomyces lavendulae</italic> (AAD28451.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">30/90</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Regulation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38555 WP_108155215.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun30 <break/>293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">class I SAM-dependent methyltransferase, 5-isoprenylindole-3-carboxylate &#x003b2;-D-glycosyl ester BGC from <italic toggle="yes">Streptomyces</italic> sp. RM-5&#x02013;8 (ANA09433.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31/85</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38560 WP_108155216.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun31 <break/>108</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">ArsR family transcriptional regulator, no hit in MiBIG database, <italic toggle="yes">Streptomyces mangrovisoli</italic> (WP_052743136.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">93/85</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Regulation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38565 WP_108155217.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun32 <break/>457</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M14 family zinc carboxypeptidase, capreomycin IA BGC from <italic toggle="yes">Saccharothrix mutabilis</italic> subsp. Capreolus (ABR67765.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45/98 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38570 WP_108155218.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun33 <break/>500</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Amino acid permease, amphotericin B biosynthetic gene cluster from <italic toggle="yes">Streptomyces nodosus</italic> (AAV48836.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">54/89</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unkown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38575 WP_257153969.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun34 <break/>450</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">glutamine synthetase family protein, colabomycin E BGC from <italic toggle="yes">Streptomyces aureus</italic> (AIL50155.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36/100</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38580 WP_108155220.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun35 <break/>190</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">MarR family transcriptional regulator, no hit in MiBIG database, <italic toggle="yes">Streptomyces</italic> sp. ISL-44 (WP_215144797.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">83/93</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Regulation</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38585 WP_108155221.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun36 <break/>268</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">acetoacetate decarboxylase family protein, enduracidin BGC from <italic toggle="yes">Streptomyces fungicidicus</italic> (ABD65946.1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35/99</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS38590 WP_108155222.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun37 <break/>846</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SpoIIE family protein phosphatase, laidlomycin BGC from <italic toggle="yes">Streptomyces</italic> sp. CS684 (AFL48546.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">48/68</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unknown</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SLUN_RS38595 WP_108155223.1 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lun38 <break/>256</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gamma-glutamyl-gamma-aminobutyrate hydrolase, nenestatin biosynthetic gene cluster from <italic toggle="yes">Micromonospora echinospora</italic> (ARD70860.1) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35/95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unknown </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">SLUN_RS41955 WP_108155224.1 </td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Lun39 <break/>495</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Putative aldehyde dehydrogenase, pederin BGC from uncultured bacterium (AAS47555.1)</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">49/100</td><td align="center" valign="middle" style="border-bottom:solid thin;background:#D9D9D9" rowspan="1" colspan="1">Unknown </td></tr></tbody></table></table-wrap><table-wrap position="float" id="ijms-24-01114-t002"><object-id pub-id-type="pii">ijms-24-01114-t002_Table 2</object-id><label>Table 2</label><caption><p>Assignment of NMR signals of the major (<bold>1</bold>) and minor (<bold>2</bold>) components of the semi purified sample.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Atom Number</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Major Compound (1)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Minor Compound (2)</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>1</sup>H NMR <italic toggle="yes"><sup>a</sup></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>13</sup>C NMR <italic toggle="yes"><sup>b</sup></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>1</sup>H NMR <italic toggle="yes"><sup>a</sup></italic></th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><sup>13</sup>C NMR <italic toggle="yes"><sup>b</sup></italic></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.27 (b, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.64 (b, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.82&#x02013;5.76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.96 (d, <italic toggle="yes">J</italic> = 11.0 Hz, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.07&#x02013;2.03</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.12&#x02013;2.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02&#x02013;0.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.02&#x02013;0.94</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82&#x02013;0.76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.82&#x02013;0.76</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">172.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">172.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88&#x02013;0.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.88&#x02013;0.84</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.92&#x02013;4.84 <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.92&#x02013;4.84 <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9&#x02013;3.1 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.9 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.75 (d, <italic toggle="yes">J</italic> = 5.6 Hz, 1H) <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.9 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.82&#x02013;5.76 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.6 <italic toggle="yes"><sup>g</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">173.5 <italic toggle="yes"><sup>h</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">171.3 <italic toggle="yes"><sup>h</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.05 (d, <italic toggle="yes">J</italic> = 13.8 Hz, 1H) <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9&#x02013;3.1 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.1 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.91 (d, <italic toggle="yes">J</italic> = 3.7 Hz, 1H) <italic toggle="yes"><sup>i</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">142.9 <italic toggle="yes"><sup>i</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.39 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.1 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.36&#x02013;5.28 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.5 <italic toggle="yes"><sup>g</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174.1 <italic toggle="yes"><sup>h</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">172.9 <italic toggle="yes"><sup>h</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.18 (d, <italic toggle="yes">J</italic> = 13.0 Hz, 1H) <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.01 (d, <italic toggle="yes">J</italic> = 14.4 Hz, 1H) <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9&#x02013;3.1 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.2 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.45 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.6 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.67 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46.7 <italic toggle="yes"><sup>g</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">173.2 <italic toggle="yes"><sup>h</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">171.6 <italic toggle="yes"><sup>h</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.23 (dd, <italic toggle="yes">J</italic> = 12.8, 3.4 Hz, 1H) <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.36&#x02013;5.28 <italic toggle="yes"><sup>c</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9&#x02013;3.1 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.3 <italic toggle="yes"><sup>d</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2&#x02013;2.3 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.4&#x02013;26.2 <italic toggle="yes"><sup>f</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">
<sup>e</sup>
</italic>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.92&#x02013;4.84 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.6 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.37 <italic toggle="yes"><sup>g</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.6 <italic toggle="yes"><sup>g</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">170.9(8)<sup>h</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">171.0(2) <italic toggle="yes"><sup>h</sup></italic></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.27 (d, <italic toggle="yes">J</italic> = 8.6 Hz, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.22 (d, <italic toggle="yes">J</italic> = 9.0 Hz, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.36&#x02013;5.28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.68 (d, <italic toggle="yes">J</italic> = 5.4 Hz, 1H)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.93&#x02013;2.86 and 2.77&#x02013;2.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.93&#x02013;2.86 and 2.77&#x02013;2.67</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137.7(1)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137.7(4)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.7(0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.7(3)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.24 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.24 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">126.6(7)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">126.6(5)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.24 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.24 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">128.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.7(0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.20&#x02013;7.14 <italic toggle="yes"><sup>j</sup></italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129.7(3)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">170.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">170.4</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes"><sup>a</sup></italic> Multiplicities, integrations and <italic toggle="yes">J</italic>-values are only shown if unambiguously characterized. <italic toggle="yes"><sup>b</sup></italic>
<sup>13</sup>C J-modulated spin echo NMR allowed us to differentiate quaternaryC/CH<sub>2</sub> from CH/CH<sub>3</sub>. <italic toggle="yes"><sup>c</sup></italic>&#x000a0;<sup>1</sup>HNMR signals attributed to N-H from piperazate residues (N-8, N-14, N-20, N-26) could be exchangeable. <italic toggle="yes"><sup>d</sup></italic> A series of overlapping <sup>1</sup>HNMR signals between 2.9 and 3.1 and a series of <sup>13</sup>CNMR signals between 46.9 and 47.3 are attributable to &#x003b4;-methylene groups (C-9, C-15, C-21 and C-27). <italic toggle="yes"><sup>e</sup></italic> Signals for methylene groups from the piperazate side chains of the minor component were not attributed due to the overlapping and/or low intensity signals. <italic toggle="yes"><sup>f</sup></italic> A series of overlapping <sup>1</sup>H NMR signals between 1.2 and 2.3 ppm and a series of <sup>13</sup>C NMR between 18.4 and 26.2 ppm are attributable to &#x003b2;- and &#x003b3;-methylene groups from the Piz residues (C-10, C-11, C-16, C-17, C-22, C-23, C-28, C-29). <italic toggle="yes"><sup>g</sup></italic>&#x000a0;<sup>1</sup>HNMR and <sup>13</sup>C NMR signals attributed to the &#x003b1; hydrogens and carbons from piperazate residues (C-12, C-18, C-24, C-30) could be exchangeable. <italic toggle="yes"><sup>h</sup></italic>&#x000a0;<sup>13</sup>C NMR signals attributed to C=O from piperazate residues (C-13, C-19, C-25) could be exchangeable. <italic toggle="yes"><sup>i</sup></italic>&#x000a0;<sup>1</sup>H NMR and <sup>13</sup>C NMR signals from the imine of the dehydro-piperazate group present in compound <bold>2</bold>. <italic toggle="yes"><sup>j</sup></italic>&#x000a0;<sup>1</sup>H NMR signals for phenylalanine aromatic carbons (C-36 to C-40) from major and minor components could not be distinguished due to overlapping.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="ijms-24-01114-t003"><object-id pub-id-type="pii">ijms-24-01114-t003_Table 3</object-id><label>Table 3</label><caption><p>Lunaemycins produced by <italic toggle="yes">S. lunaelactis</italic> MM109<sup>T</sup> and MM37.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Nb</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">RT (min) </th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">m</italic>/<italic toggle="yes">z</italic> Observed [M+H]<sup>+</sup>/[M+Na]<sup>+</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Formula [M+H]<sup>+</sup>/[M+Na]<sup>+</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x00394;m (ppm)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">18.35</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin A</td><td align="center" valign="middle" rowspan="1" colspan="1">725.4092/747.3903</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2a</td><td align="center" valign="middle" rowspan="1" colspan="1">17.42</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin B1</td><td align="center" valign="middle" rowspan="1" colspan="1">723.3935/745.3749</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>51</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>50</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2/0.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">2b</td><td align="center" valign="middle" rowspan="1" colspan="1">17.74</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin B2</td><td align="center" valign="middle" rowspan="1" colspan="1">723.3935/745.3749</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>51</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>50</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2/0.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3a</td><td align="center" valign="middle" rowspan="1" colspan="1">16.94</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin C1</td><td align="center" valign="middle" rowspan="1" colspan="1">721.3779/743.3594</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>49</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>48</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3b</td><td align="center" valign="middle" rowspan="1" colspan="1">17.27</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin C2</td><td align="center" valign="middle" rowspan="1" colspan="1">721.3777/743.3594</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>49</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>48</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.4/0.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">16.82</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin D</td><td align="center" valign="middle" rowspan="1" colspan="1">739.3886/761.3698</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>51</sub>N<sub>10</sub>O<sub>8</sub><sup>+</sup>/C<sub>35</sub>H<sub>50</sub>N<sub>10</sub>O<sub>8</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5a</td><td align="center" valign="middle" rowspan="1" colspan="1">15.91</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin E1</td><td align="center" valign="middle" rowspan="1" colspan="1">737.3731/759.3546</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>49</sub>N<sub>10</sub>O<sub>8</sub><sup>+</sup>/C<sub>35</sub>H<sub>48</sub>N<sub>10</sub>O8Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2/0.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">5b</td><td align="center" valign="middle" rowspan="1" colspan="1">16.44</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin E2</td><td align="center" valign="middle" rowspan="1" colspan="1">737.3731/759.3546</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>49</sub>N<sub>10</sub>O<sub>8</sub><sup>+</sup>/C<sub>35</sub>H<sub>48</sub>N<sub>10</sub>O<sub>8</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.6/1.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">15.60</td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin F</td><td align="center" valign="middle" rowspan="1" colspan="1">741.4042/763.3856</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>8</sub><sup>+</sup>/C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>8</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/0.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">7 </td><td align="center" valign="middle" rowspan="1" colspan="1">13.76 </td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin G </td><td align="center" valign="middle" rowspan="1" colspan="1">755.3832/777.3647 </td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>51</sub>N<sub>10</sub>O<sub>9</sub><sup>+</sup>/C<sub>35</sub>H<sub>50</sub>N<sub>10</sub>O<sub>9</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3/0.9 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">8 </td><td align="center" valign="middle" rowspan="1" colspan="1">12.81 </td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin H </td><td align="center" valign="middle" rowspan="1" colspan="1">757.399/779.3806 </td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>9</sub><sup>+</sup>/C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/0.3 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">9 </td><td align="center" valign="middle" rowspan="1" colspan="1">17.59 </td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin I </td><td align="center" valign="middle" rowspan="1" colspan="1">711.3935/733.3751 </td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>34</sub>H<sub>51</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>34</sub>H<sub>48</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.1/0.8 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10a </td><td align="center" valign="middle" rowspan="1" colspan="1">16.70 </td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin J1 </td><td align="center" valign="middle" rowspan="1" colspan="1">709.3784/731.3603 </td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>34</sub>H<sub>49</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>34</sub>H<sub>48</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3/0.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">10b </td><td align="center" valign="middle" rowspan="1" colspan="1">17. 10 </td><td align="center" valign="middle" rowspan="1" colspan="1">Lunaemycin J2 </td><td align="center" valign="middle" rowspan="1" colspan="1">709.3777/731.3594 </td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>34</sub>H<sub>49</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>34</sub>H<sub>48</sub>N<sub>10</sub>O<sub>7</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.3/0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10c </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17.40 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lunaemycin J3 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">709.4141/731.3951 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C<sub>35</sub>H<sub>53</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/C<sub>35</sub>H<sub>52</sub>N<sub>10</sub>O<sub>6</sub>Na<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3/0.1</td></tr><tr><td colspan="6" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Additional lunaemycin derivatives with non-elucidated structure</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">11</td><td align="center" valign="middle" rowspan="1" colspan="1">11.73 </td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">753.3666/775.3492</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>49</sub>N<sub>10</sub>O<sub>9</sub><sup>+</sup>/C<sub>35</sub>H<sub>48</sub>N<sub>10</sub>O<sub>9</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.7/0.8 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">11.79 </td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">771.3785/793.36</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>51</sub>N<sub>10</sub>O<sub>10</sub><sup>+</sup>/C<sub>35</sub>H<sub>50</sub>N<sub>10</sub>O<sub>10</sub>Na<sup>+</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0.2/0.5 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">13</td><td align="center" valign="middle" rowspan="1" colspan="1">15.91 </td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">754.3993</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>52</sub>N<sub>11</sub>O<sub>8</sub><sup>+</sup>/ND </td><td align="center" valign="middle" rowspan="1" colspan="1">0.3 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">14</td><td align="center" valign="middle" rowspan="1" colspan="1">16.84 </td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">613.346</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>30</sub>H<sub>45</sub>N<sub>8</sub>O<sub>6</sub><sup>+</sup>/ND </td><td align="center" valign="middle" rowspan="1" colspan="1">0.4 </td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">15</td><td align="center" valign="middle" rowspan="1" colspan="1">18.33 </td><td align="center" valign="middle" rowspan="1" colspan="1">-</td><td align="center" valign="middle" rowspan="1" colspan="1">742.436</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>35</sub>H<sub>56</sub>N<sub>10</sub>O<sub>7</sub><sup>+</sup>/ND </td><td align="center" valign="middle" rowspan="1" colspan="1">1.2 </td></tr><tr><td colspan="6" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">The numbers attributed to the different lunaemycins refer to the peaks displayed in EIC of <xref rid="ijms-24-01114-f007" ref-type="fig">Figure 7</xref>.</td></tr></tbody></table></table-wrap><table-wrap position="float" id="ijms-24-01114-t004"><object-id pub-id-type="pii">ijms-24-01114-t004_Table 4</object-id><label>Table 4</label><caption><p>In vitro antibacterial activity (MIC and MBC values) of lunaemycin A on reference strains and clinical isolates with various phenotypes of resistance to antibiotics.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Organism</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MIC (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MBC (&#x000b5;g/mL)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comparator (MIC, &#x000b5;g/mL) <italic toggle="yes"><sup>a</sup></italic></th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gram-positive bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Bacillus subtilis</italic> ATCC 6633</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Van, 0.5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Enterococcus faecalis</italic> ATCC 29212</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Van, 1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Streptococcus pyogenes</italic> ATCC 12344</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Van, 1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus aureus</italic> ATCC 25923</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Van, 0.5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Enterococcus faecalis</italic> SI-759</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin<sup>R</sup>, teicoplanin<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tei, 4 </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Enterococcus faecium</italic> SI-1831</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vancomycin<sup>R</sup>, teicoplanin<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tei, 32</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus aureus</italic> ATCC 43300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Methicillin<sup>R</sup>, MRSA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxa, 32 </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus epidermidis</italic> SI-1266</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Linezolid<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.25 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lin, 64</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus haemolyticus</italic> SI-6/2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gentamicin<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gen, &#x0003e;32 </td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Staphylococcus warneri</italic> SI-5/2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxacillin<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.12 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oxa, 32</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gram-negative bacteria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Acinetobacter baumannii</italic> ATCC 17978</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> CCUG<sup>T</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 0.5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> ATCC 13833</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 0.5</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas aeruginosa</italic> ATCC 27853</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">-</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">- </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 1</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Acinetobacter baumannii</italic> N50</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, carbapenem<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mer, 32</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> SI-63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, colistin<sup>R</sup>, mcr<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 8</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> MO287</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, NDM-1<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mer, 64</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> SI-1896</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, OXA-48-like<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mer, &#x0003e;16</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> B2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pandrug-resistant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 128</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> BO4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pandrug-resistant</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 64</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> SI-518</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, NDM-1<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mer, 128</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Klebsiella pneumoniae</italic> SI-703A</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, OXA-48-like<sup>+</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mer, &#x0003e;16</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Pseudomonas aeruginosa</italic> SI-270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MDR, colistin<sup>R</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Col, 16</td></tr></tbody></table><table-wrap-foot><fn><p><italic toggle="yes"><sup>a</sup></italic> Van, vancomycin; Tei, teicoplanin; Oxa, oxacillin; Lin, linezolid; Gen, gentamicin; Col, colistin; Mer, meropenem. <sup>R</sup>, resistant; <sup>+</sup>, presence of the associated resistance gene.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="ijms-24-01114-t005"><object-id pub-id-type="pii">ijms-24-01114-t005_Table 5</object-id><label>Table 5</label><caption><p>List of bacterial strains used in this study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacteria</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref Number</th><th align="left" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comment/Utilization</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origin</th></tr><tr><th colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1"><italic toggle="yes">Streptomyces</italic> Strains</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM109<sup>T</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DSM 42149</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28a in pSLUN1a, type strain. Lunaemycin producer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28a in pSLUN1a. Lunaemycin producer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM25</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM78</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM113</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">S</italic>. <italic toggle="yes">lunaelactis</italic> MM115</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BGC 28b in pSLUN1b</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Hedera 22</td></tr><tr><td colspan="4" align="left" valign="middle" style="border-bottom:solid thin" rowspan="1">Strains used for antibacterial assays</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Acinetobacter baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 17978</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Acinetobacter baumannii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N50</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, carbapnem<sup>R</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 6633</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Bacillus subtilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 19659</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Citrobacter freundii</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 43864</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCUG<sup>T</sup></td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 25922</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-63</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, colistin<sup>R</sup>, mcr<sup>+</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MO287</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, NDM-1<sup>+</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-1896</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, OXA-48-like<sup>+</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 29212</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-759</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (vancomycin<sup>R</sup>, teicoplanin<sup>R</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus faecium</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-1831</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (vancomycin<sup>R</sup>, teicoplanin<sup>R</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Enterococcus hirae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 9790</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 13833</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B2</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (pandrug-resistant)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BO4</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (pandrug-resistant)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-518</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, NDM-1<sup>+</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-703A</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, OXA-48-like<sup>+</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">Kocuria rhizophila</italic> (<italic toggle="yes">Micrococcus luteus</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 9341</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Proteus mirabilis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 7002</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 27853</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-270</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (MDR, colistin<sup>R</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Serratia marcescens</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 10759</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pyogenes</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 12344</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 25923</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reference strain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ULi&#x000e8;ge/Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ATCC 43300</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (methicillin<sup>R</sup>, MRSA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus epidermidis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-1266</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (linezolid<sup>R</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus haemolyticus</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-6/2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (gentamicin<sup>R)</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus warneri</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI-5/2011</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical isolate (oxacillin<sup>R)</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Universit&#x000e0; di Siena</td></tr></tbody></table><table-wrap-foot><fn><p><sup>R</sup>, resistant; <sup>+</sup>, presence of the associated resistance gene.</p></fn></table-wrap-foot></table-wrap></floats-group></article>